Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 46
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort

  • Molina Montes, Esther
  • Sánchez, María José
  • Buckland, Genevieve
  • Bueno de Mesquita, H. Bas
  • Weiderpass, Elisabete
  • Amiano, Pilar
  • Wark, Petra A.
  • Kühn, Tilman
  • Katzke, Verena
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Quirós, José Ramón
  • Affret, Aurélie
  • His, Mathilde
  • Boutron-Ruault, Marie-Christine
  • Peeters, Petra H. M.
  • Ye, Weimin
  • Sund, Malin
  • Boeing, Heiner
  • Iqbal, Khalid
  • Ohlsson, Bodil
  • Sonestedt, Emily
  • Tjønneland, Anne
  • Petersen, Kristina Elin Nielsen
  • Travis, Ruth C.
  • Skeie, Guri
  • Agnoli, Claudia
  • Panico, Salvatore
  • Palli, Domenico
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Freisling, Heinz
  • Huybrechts, Inge
  • Overvad, Kim
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Vasilopoulou, Effie
  • Wareham, Nicholas J.
  • Khaw, Kay-Tee
  • Cross, Amanda J.
  • Ward, Heather A.
  • Riboli, Elio
  • Duell, Eric J.
Background: The Mediterranean diet (MD) has been proposed as a means for cancer prevention, but little evidence has been accrued regarding its potential to prevent pancreatic cancer. We investigated the association between the adherence to the MD and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Methods: Over half a million participants from 10 European countries were followed up for over 11 years, after which 865 newly diagnosed exocrine pancreatic cancer cases were identified. Adherence to the MD was estimated through an adapted score without the alcohol component (arMED) to discount alcohol-related harmful effects. Cox proportional hazards regression models, stratified by age, sex and centre, and adjusted for energy intake, body mass index, smoking status, alcohol intake and diabetes status at recruitment, were used to estimate hazard ratios (HRs) associated with pancreatic cancer and their corresponding 95% confidence intervals (CIs). Results: Adherence to the arMED score was not associated with risk of pancreatic cancer (HR high vs low adherence = 0.99; 95% CI: 0.77-1.26, and HR per increments of two units in adherence to arMED = 1.00; 95% CI: 0.94-1.06). There was no convincing evidence for heterogeneity by smoking status, body mass index, diabetes or European region. There was also no evidence of significant associations in analyses involving microscopically confirmed cases, plausible reporters of energy intake or other definitions of the MD pattern. Conclusions: A high adherence to the MD is not associated with pancreatic cancer risk in the EPIC study.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study

  • Aleksandrova, Krasimira
  • Pischon, Tobias
  • Jenab, Mazda
  • Bueno de Mesquita, H. Bas
  • Fedirko, Veronika
  • Norat, Teresa
  • Romaguera, Dora
  • Knüppel, Sven
  • Boutron-Ruault, Marie-Christine
  • Dossus, Laure
  • Dartois, Laureen
  • Kaaks, Rudolf
  • Li, Kuanrong
  • Tjønneland, Anne
  • Overvad, Kim
  • Quirós, José Ramón
  • Buckland, Genevieve
  • Sánchez, María José
  • Dorronsoro, Miren
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Khaw, Kay-Tee
  • Wareham, Nicholas J.
  • Bradbury, Kathryn E.
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Krogh, Vittorio
  • Tumino, Rosario
  • Naccarati, Alessio
  • Panico, Salvatore
  • Siersema, Peter D.
  • Peeters, Petra H. M.
  • Ljuslinder, Ingrid
  • Johansson, Ingegerd
  • Ericson, Ulrika
  • Ohlsson, Bodil
  • Weiderpass, Elisabete
  • Skeie, Guri
  • Benjaminsen Borch, Kristin
  • Rinaldi, Sabina
  • Romieu, Isabelle
  • Kong, Joyce
  • Gunter, Marc J.
  • Ward, Heather A.
  • Riboli, Elio
  • Boeing, Heiner
Background: Excess body weight, physical activity, smoking, alcohol consumption and certain dietary factors are individually related to colorectal cancer (CRC) risk; however, little is known about their joint effects. The aim of this study was to develop a healthy lifestyle index (HLI) composed of five potentially modifiable lifestyle factors healthy weight, physical activity, non-smoking, limited alcohol consumption and a healthy diet, and to explore the association of this index with CRC incidence using data collected within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Methods: In the EPIC cohort, a total of 347,237 men and women, 25- to 70-years old, provided dietary and lifestyle information at study baseline (1992 to 2000). Over a median follow-up time of 12 years, 3,759 incident CRC cases were identified. The association between a HLI and CRC risk was evaluated using Cox proportional hazards regression models and population attributable risks (PARs) have been calculated. Results: After accounting for study centre, age, sex and education, compared with 0 or 1 healthy lifestyle factors, the hazard ratio (HR) for CRC was 0.87 (95% confidence interval (CI): 0.44 to 0.77) for two factors, 0.79 (95% CI: 0.70 to 0.89) for three factors, 0.66 (95% CI: 0.58 to 0.75) for four factors and 0.63 (95% CI: 0.54 to 0.74) for five factors; P-trend <0.0001. The associations were present for both colon and rectal cancers, HRs, 0.61 (95% CI: 0.50 to 0.74; P for trend <0.0001) for colon cancer and 0.68 (95% CI: 0.53 to 0.88; P-trend <0.0001) for rectal cancer, respectively (P-difference by cancer sub-site = 0.10). Overall, 16% of the new CRC cases (22% in men and 11% in women) were attributable to not adhering to a combination of all five healthy lifestyle behaviours included in the index. Conclusions: Combined lifestyle factors are associated with a lower incidence of CRC in European populations characterized by western lifestyles. Prevention strategies considering complex targeting of multiple lifestyle factors may provide practical means for improved CRC prevention.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Circulating Metabolites Associated With Alcohol Intake In The European Prospective Investigation Into Cancer And Nutrition Cohort

  • Van Roekel, Eline H.
  • Trijsburg, Laura
  • Assi, Nada
  • Carayol, Marion
  • Achaintre, David
  • Murphy, Neil
  • Rinaldi, Sabina
  • Schmidt, Julie A.
  • Stepien, Magdalena
  • Kaaks, Rudolf
  • Kuhn, Tilman
  • Boeing, Heiner
  • Iqbal, Khalid
  • Palli, Domenico
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Panico, Salvatore
  • Peeters, Petra H. M.
  • Bueno de Mesquita, H. Bas
  • Ardanaz, Eva
  • Luján Barroso, Leila
  • Quirós, José Ramón
  • Huerta Castaño, José María
  • Molina Portillo, Elena
  • Dorronsoro, Miren
  • Tsilidis, Konstantinos K.
  • Riboli, Elio
  • Rostgaard-Hansen, Agnetha Linn
  • Tjønneland, Anne
  • Overvad, Kim
  • Weiderpass, Elisabete
  • Boutron-Ruault, Marie-Christine
  • Severi, Gianluca
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Kotanidou, Anastasia
  • Hakänsson, Anders
  • Malm, Johan
  • Weijenberg, Matty P.
  • Gunter, Marc J.
  • Jenab, Mazda
  • Johansson, Mattias
  • Travis, Ruth C.
  • Scalbert, Augustin
  • Ferrari, Pietro
Identifying the metabolites associated with alcohol consumption may provide insights into the metabolic pathways through which alcohol may affect human health. We studied associations of alcohol consumption with circulating concentrations of 123 metabolites among 2974 healthy participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Alcohol consumption at recruitment was self-reported through dietary questionnaires. Metabolite concentrations were measured by tandem mass spectrometry (BIOCRATES AbsoluteIDQTM p180 kit). Data were randomly divided into discovery (2/3) and replication (1/3) sets. Multivariable linear regression models were used to evaluate confounder-adjusted associations of alcohol consumption with metabolite concentrations. Metabolites significantly related to alcohol intake in the discovery set (FDR q-value < 0.05) were further tested in the replication set (Bonferroni-corrected p-value < 0.05). Of the 72 metabolites significantly related to alcohol intake in the discovery set, 34 were also significant in the replication analysis, including three acylcarnitines, the amino acid citrulline, four lysophosphatidylcholines, 13 diacylphosphatidylcholines, seven acyl-alkylphosphatidylcholines, and six sphingomyelins. Our results confirmed earlier findings that alcohol consumption was associated with several lipid metabolites, and possibly also with specific acylcarnitines and amino acids. This provides further leads for future research studies aiming at elucidating the mechanisms underlying the effects of alcohol in relation to morbid conditions.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

  • van Duijnhoven, Franzel J. B.
  • Jenab, Mazda
  • Hveem, Kristian
  • Siersema, Peter D.
  • Fedirko, Veronika
  • Duell, Eric J.
  • Kampman, Ellen
  • Halfweeg, Anouk
  • van Kranen, Henk J.
  • van den Ouweland, Jody M. W.
  • Weiderpass, Elisabete
  • Murphy, Neil
  • Langhammer, Arnulf
  • Ness-Jensen, Eivind
  • Olsen, Anja
  • Tjønneland, Anne
  • Overvad, Kim
  • Cadeau, Claire
  • Kvaskoff, Marina
  • Boutron-Ruault, Marie-Christine
  • Katzke, Verena
  • Kühn, Tilman
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Kotanidou, Anastasia
  • Kritikou, Maria
  • Palli, Domenico
  • Agnoli, Claudia
  • Tumino, Rosario
  • Panico, Salvatore
  • Matullo, Giuseppe
  • Peeters, Petra H. M.
  • Brustad, Magritt
  • Olsen, Karina Standahl
  • Lasheras, Cristina
  • Obón Santacana, Mireia
  • Sánchez, María José
  • Dorronsoro, Miren
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Manjer, Jonas
  • Almquist, Martin
  • Renström, Frida
  • Ye, Weimin
  • Wareham, Nick
  • Khaw, Kay-Tee
  • Bradbury, Kathryn E.
  • Freisling, Heinz
  • Aune, Dagfinn
  • Norat, Teresa
  • Riboli, Elio
  • Bueno de Mesquita, H. Bas
Evidence from in vivo, in vitro and ecological studies are suggestive of a protective effect of vitamin D against pancreatic cancer (PC). However, this has not been confirmed by analytical epidemiological studies. We aimed to examine the association between pre-diagnostic circulating vitamin D concentrations and PC incidence in European populations. We conducted a pooled nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Nord-Trøndelag Health Study's second survey (HUNT2) cohorts. In total, 738 primary incident PC cases (EPIC n = 626; HUNT2 n = 112; median follow-up = 6.9 years) were matched to 738 controls. Vitamin D [25(OH)D2 and 25(OH)D3 combined] concentrations were determined using isotope-dilution liquid chromatography-tandem mass spectrometry. Conditional logistic regression models with adjustments for body mass index and smoking habits were used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (95%CI). Compared with a reference category of >50 to 75 nmol/L vitamin D, the IRRs (95% CIs) were 0.71 (0.42-1.20); 0.94 (0.72-1.22); 1.12 (0.82-1.53) and 1.26 (0.79-2.01) for clinically pre-defined categories of ≤25; >25 to 50; >75 to 100; and >100 nmol/L vitamin D, respectively (p for trend = 0.09). Corresponding analyses by quintiles of season-standardized vitamin D concentrations also did not reveal associations with PC risk (p for trend = 0.23). Although these findings among participants from the largest combination of European cohort studies to date show increasing effect estimates of PC risk with increasing pre-diagnostic concentrations of vitamin D, they are not statistically significant.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts

  • Li, Kuanrong
  • Anderson, Garnet
  • Viallon, Vivian
  • Arveux, Patrick
  • Kvaskoff, Marina
  • Fournier, Agnès
  • Krogh, Vittorio
  • Tumino, Rosario
  • Sánchez, María José
  • Ardanaz, Eva
  • Chirlaque, María Dolores
  • Agudo, Antonio
  • Muller, David C.
  • Smith, Todd
  • Tzoulaki, Ioanna
  • Key, Timothy J.
  • Bueno de Mesquita, H. Bas
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Kaaks, Rudolf
  • Hüsing, Anika
  • Fortner, Renée T.
  • Zeleniuch-Jacquotte, Anne
  • Sund, Malin
  • Dahm, Christina C.
  • Overvad, Kim
  • Aune, Dagfinn
  • Weiderpass, Elisabete
  • Romieu, Isabelle
  • Riboli, Elio
  • Gunter, Marc J.
  • Dossus, Laure
  • Prentice, Ross L.
  • Ferrari, Pietro
Background: Few published breast cancer (BC) risk prediction models consider the heterogeneity of predictor variables between estrogen-receptor positive (ER+) and negative (ER-) tumors. Using data from two large cohorts, we examined whether modeling this heterogeneity could improve prediction. Methods: We built two models, for ER+ (ModelER+) and ER- tumors (ModelER-), respectively, in 281,330 women (51% postmenopausal at recruitment) from the European Prospective Investigation into Cancer and Nutrition cohort. Discrimination (C-statistic) and calibration (the agreement between predicted and observed tumor risks) were assessed both internally and externally in 82,319 postmenopausal women from the Women’s Health Initiative study. We performed decision curve analysis to compare ModelER+ and the Gail model (ModelGail) regarding their applicability in risk assessment for chemoprevention. Results: Parity, number of full-term pregnancies, age at first full-term pregnancy and body height were only associated with ER+ tumors. Menopausal status, age at menarche and at menopause, hormone replacement therapy, postmenopausal body mass index, and alcohol intake were homogeneously associated with ER+ and ER- tumors. Internal validation yielded a C-statistic of 0.64 for ModelER+ and 0.59 for ModelER-. External validation reduced the C-statistic of ModelER+ (0.59) and ModelGail (0.57). In external evaluation of calibration, ModelER+ outperformed the ModelGail: the former led to a 9% overestimation of the risk of ER+ tumors, while the latter yielded a 22% underestimation of the overall BC risk. Compared with the treat-all strategy, ModelER+ produced equal or higher net benefits irrespective of the benefit-to-harm ratio of chemoprevention, while ModelGail did not produce higher net benefits unless the benefit-to-harm ratio was below 50. The clinical applicability, i.e. the area defined by the net benefit curve and the treat-all and treat-none strategies, was 12.7 × 10− 6 for ModelER+ and 3.0 × 10− 6 for ModelGail. Conclusions: Modeling heterogeneous epidemiological risk factors might yield little improvement in BC risk prediction. Nevertheless, a model specifically predictive of ER+ tumor risk could be more applicable than an omnibus model in risk assessment for chemoprevention.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies

  • Smith, Todd
  • Muller, David C.
  • Moons, Karel G. M.
  • Cross, Amanda J.
  • Johansson, Mattias
  • Ferrari, Pietro
  • Fagherazzi, Guy
  • Peeters, Petra H. M.
  • Severi, Gianluca
  • Hüsing, Anika
  • Kaaks, Rudolf
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Bonet Bonet, Catalina
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Barricarte, Aurelio
  • Bradbury, Kathryn E.
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Palli, Domenico
  • Pala, Valeria
  • Vineis, Paolo
  • Bueno de Mesquita, H. Bas
  • Ohlsson, Bodil
  • Harlid, Sophia
  • Van Guelpen, Bethany
  • Skeie, Guri
  • Weiderpass, Elisabete
  • Jenab, Mazda
  • Murphy, Neil
  • Riboli, Elio
  • Gunter, Marc J.
  • Aleksandrova, Krasimira
  • Tzoulaki, Ioanna
Objective: To systematically identify and validate published colorectal cancer risk prediction models that do not require invasive testing in two large population-based prospective cohorts. Design: Models were identified through an update of a published systematic review and validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) and the UK Biobank. The performance of the models to predict the occurrence of colorectal cancer within 5 or 10 years after study enrolment was assessed by discrimination (C-statistic) and calibration (plots of observed vs predicted probability). Results: The systematic review and its update identified 16 models from 8 publications (8 colorectal, 5 colon and 3 rectal). The number of participants included in each model validation ranged from 41 587 to 396 515, and the number of cases ranged from 115 to 1781. Eligible and ineligible participants across the models were largely comparable. Calibration of the models, where assessable, was very good and further improved by recalibration. The C-statistics of the models were largely similar between validation cohorts with the highest values achieved being 0.70 (95% CI 0.68 to 0.72) in the UK Biobank and 0.71 (95% CI 0.67 to 0.74) in EPIC. Conclusion: Several of these non-invasive models exhibited good calibration and discrimination within both external validation populations and are therefore potentially suitable candidates for the facilitation of risk stratification in population-based colorectal screening programmes. Future work should both evaluate this potential, through modelling and impact studies, and ascertain if further enhancement in their performance can be obtained.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Gaia Data Release 1: the archive visualisation service

  • Moitinho, A.
  • Krone-Martins, A.
  • Savietto, H.
  • Barros, M.
  • Barata, C.
  • Falcão, A. J.
  • Fernandes, T.
  • Alves, J.
  • Gomes, M.
  • Bakker, J.
  • Brown, A. G. A.
  • González-Núñez, J.
  • Gràcia Abril, G.
  • Gutiérrez-Sánchez, R.
  • Hernández, J.
  • Jordan, S.
  • Luri Carrascoso, Xavier
  • Merin, B.
  • Mignard, F.
  • Mora, A.
  • Navarro, Vicente
  • O&apos;Mullane, William
  • Sagristà, T.
  • Salgado, J.
  • Segovia, J. C.
  • Utrilla, E.
  • Arenou, Frédéric
  • Bruijne, J. H. J. de
  • Jansen, F.
  • McCaughrean, M.
  • O&apos;Flaherty, K. S.
  • Prusti, Timo
  • Taylor, M. B.
  • Vallenari, A.
Context. The first Gaia data release (DR1) delivered a catalogue of astrometry and photometry for over a billion astronomical sources. Within the panoplyof methods used for data exploration, visualisation is often the starting point and even the guiding reference for scientific thought. However, this is a volume of data that cannot be efficiently explored using traditional tools, techniques, and habits. Aims. We aim to provide a global visual exploration service for the Gaia archive, something that is not possible out of the box for most people. The service has two main goals. The first is to provide a software platform for interactive visual exploration of the archive contents, using common personal computers and mobile devices available to most users. The second aim is to produce intelligible and appealing visual representations of the enormous information content of the archive. Methods. The interactive exploration service follows a client-server design. The server runs close to the data, at the archive, and is responsible for hiding as far as possible the complexity and volume of the Gaia data from the client. This is achieved by serving visual detail on demand. Levels of detail are pre-computed using data aggregation and subsampling techniques. For DR1, the client is a web application that provides an interactive multi-panel visualisation workspace as well as a graphical user interface. Results. The Gaia archive Visualisation Service offers a web-based multi-panel interactive visualisation desktop in a browser tab. It currently provides highly configurable 1D histograms and 2D scatter plots of Gaia DR1 and the Tycho-Gaia Astrometric Solution (TGAS) with linked views. An innovative feature is the creation of ADQL queries from visually defined regions in plots. These visual queries are ready for use in the Gaia Archive Search/data retrieval service. In addition, regions around user-selected objects can be further examined with automatically generated SIMBAD searches. Integration of the Aladin Lite and JS9 applications add support to the visualisation of HiPS and FITS maps. The production of the all-sky source density map that became the iconic image of Gaia DR1 is described in detail. Conclusions. On the day of DR1, over seven thousand users accessed the Gaia Archive visualisation portal. The system, running on a single machine, proved robust and did not fail while enabling thousands of users to visualise and explore the over one billion sources in DR1. There are still several limitations, most noticeably that users may only choose from a list of pre-computed visualisations. Thus, other visualisation applications that can complement the archive service are examined. Finally, development plans for Data Release 2 are presented.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

  • Sarink, Danja
  • Schock, Helena
  • Johnson, Theron
  • Chang-Claude, Jenny
  • Overvad, Kim
  • Olsen, Anja
  • Tjønneland, Anne
  • Arveux, Patrick
  • Fournier, Agnès
  • Kvaskoff, Marina
  • Boeing, Heiner
  • Karakatsani, Anna
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Masala, Giovanni
  • Agnoli, Claudia
  • Panico, Salvatore
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • van Gils, Carla H.
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Agudo, Antonio
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Gil, Leire
  • Kaw, Kay Tee
  • Schmidt, Julie A.
  • Dossus, Laure
  • His, Mathilde
  • Aune, Dagfinn
  • Riboli, Elio
  • Kaaks, Rudolf
  • Fortner, Renée T.
Background: Receptor activator of nuclear factor kappa-B (RANK)-signaling is involved in tumor growth and spread in experimental models. Binding of RANK ligand (RANKL) to RANK activates signaling, which is inhibited by osteoprotegerin (OPG). We have previously shown that circulating soluble RANKL (sRANKL) and OPG are associated with breast cancer risk. Here we extend these findings to provide the first data on pre-diagnosis concentrations of sRANKL and OPG and risk of breast cancer-specific and overall mortality after a breast cancer diagnosis. Methods: Two thousand six pre- and postmenopausal women with incident invasive breast cancer (1620 (81%) with ER+ disease) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort were followed-up for mortality. Pre-diagnosis concentrations of sRANKL and OPG were quantified in baseline serum samples using an enzyme-linked immunosorbent assay and electrochemiluminescent assay, respectively. Hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer-specific and overall mortality were calculated using Cox proportional hazards regression models. Results: Especially in women with ER+ disease, higher circulating OPG concentrations were associated with higher risk of breast cancer-specific (quintile 5 vs 1 HR 1.77 [CI 1.03, 3.04]; ptrend 0.10) and overall mortality (q5 vs 1 HR 1.39 [CI 0.94, 2.05]; ptrend 0.02). sRANKL and the sRANKL/OPG ratio were not associated with mortality following a breast cancer diagnosis. Conclusions: High pre-diagnosis endogenous concentrations of OPG, the decoy receptor for RANKL, were associated with increased risk of death after a breast cancer diagnosis, especially in those with ER+ disease. These results need to be confirmed in well-characterized patient cohorts.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Development and validation of circulating CA125 prediction models in postmenopausal women

  • Sasamoto, Naoko
  • Babic, Ana
  • Rosner, Bernard A.
  • Fortner, Renée T.
  • Vitonis, Allison F.
  • Yamamoto, Hidemi
  • Fichorova, Raina N.
  • Titus, Linda J.
  • Tjønneland, Anne
  • Hansen, Louise
  • Kvaskoff, Marina
  • Fournier, Agnès
  • Mancini, Francesca Romana
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Peppa, Eleni
  • Karakatsani, Anna
  • Palli, Domenico
  • Grioni, Sara
  • Mattiello, Amalia
  • Tumino, Rosario
  • Fiano, Valentina
  • Onland-Moret, N. Charlotte
  • Weiderpass, Elisabete
  • Gram, Inger T.
  • Quirós, José Ramón
  • Luján Barroso, Leila
  • Sánchez, María José
  • Colorado-Yohar, Sandra
  • Barricarte, Aurelio
  • Amiano, Pilar
  • Idahl, Annika
  • Lundin, Eva
  • Sartor, Hanna
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Muller, David C.
  • Riboli, Elio
  • Gunter, Marc J.
  • Dossus, Laure
  • Trabert, Britton
  • Wentzensen, Nicolas
  • Kaaks, Rudolf
  • Cramer, Daniel W.
  • Tworoger, Shelley S.
  • Terry, Kathryn L.
Background Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal characteristics that influence CA125 could be used to improve its performance as screening biomarker. Methods We developed and validated linear and dichotomous (>= 35 U/mL) circulating CA125 prediction models in postmenopausal women without ovarian cancer who participated in one of five large population-based studies: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, n = 26,981), European Prospective Investigation into Cancer and Nutrition (EPIC, n = 861), the Nurses' Health Studies (NHS/NHSII, n = 81), and the New England Case Control Study (NEC, n = 923). The prediction models were developed using stepwise regression in PLCO and validated in EPIC, NHS/NHSII and NEC. Result The linear CA125 prediction model, which included age, race, body mass index (BMI), smoking status and duration, parity, hysterectomy, age at menopause, and duration of hormone therapy (HT), explained 5% of the total variance of CA125. The correlation between measured and predicted CA125 was comparable in PLCO testing dataset (r = 0.18) and external validation datasets (r = 0.14). The dichotomous CA125 prediction model included age, race, BMI, smoking status and duration, hysterectomy, time since menopause, and duration of HT with AUC of 0.64 in PLCO and 0.80 in validation dataset. Conclusions The linear prediction model explained a small portion of the total variability of CA125, suggesting the need to identify novel predictors of CA125. The dichotomous prediction model showed moderate discriminatory performance which validated well in independent dataset. Our dichotomous model could be valuable in identifying healthy women who may have elevated CA125 levels, which may contribute to reducing false positive tests using CA125 as screening biomarker.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study

  • Tikk, Kaja
  • Sookthai, Disorn
  • Fortner, Renée T.
  • Johnson, Theron
  • Rinaldi, Sabina
  • Romieu, Isabelle
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Clavel-Chapelon, Françoise
  • Baglietto, Laura
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Masala, Giovanna
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Mattiello, Amalia
  • Agudo, Antonio
  • Menéndez, Virginia
  • Sánchez, María José
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Bueno de Mesquita, H. Bas
  • Monninkhof, Evelyn M.
  • Onland-Moret, N. Charlotte
  • Andresson, Anne
  • Sund, Malin
  • Weiderpass, Elisabete
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Travis, Ruth C.
  • Merritt, Melissa A.
  • Riboli, Elio
  • Dossus, Laure
  • Kaaks, Rudolf
Introduction: The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention. Methods: We analysed the relationship between pre-diagnostic prolactin levels and the risk of in situ breast cancer overall, and by menopausal status and use of postmenopausal hormone therapy (HT) at blood donation. Conditional logistic regression was used to assess this association in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, including 307 in situ breast cancer cases and their matched control subjects. Results: We found a significant positive association between higher circulating prolactin levels and risk of in situ breast cancer among all women [pre-and postmenopausal combined, ORlog2 = 1.35 (95% CI 1.04-1.76), P-trend = 0.03]. No statistically significant heterogeneity was found between prolactin levels and in situ cancer risk by menopausal status (P-het = 0.98) or baseline HT use (P-het = 0.20), although the observed association was more pronounced among postmenopausal women using HT compared to non-users (P-trend = 0.06 vs P-trend = 0.35). In subgroup analyses, the observed positive association was strongest in women diagnosed with in situ breast tumors <4 years compared to >= 4 years after blood donation (P-trend = 0.01 vs P-trend = 0.63; P-het = 0.04) and among nulliparous women compared to parous women (P-trend = 0.03 vs P-trend = 0.15; P-het = 0.07). Conclusions: Our data extends prior research linking prolactin and invasive breast cancer to the outcome of in situ breast tumours and shows that higher circulating prolactin is associated with increased risk of in situ breast cancer. The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort

  • Idahl, Annika
  • Cornet, Charlotte Le
  • González Maldonado, Sandra
  • Waterboer, Tim
  • Bender, Noemi
  • Tjønneland, Anne
  • Hansen, Louise
  • Boutron-Ruault, Marie-Christine
  • Fournier, Agnès
  • Kvaskoff, Marina
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Valanou, Elisavet
  • Peppa, Eleni
  • Palli, Domenico
  • Agnoli, Claudia
  • Mattiello, Amalia
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Onland-Moret, N. Charlotte
  • Gram, Inger T.
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Duell, Eric J.
  • Sánchez, María José
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Gil, Leire
  • Brändstedt, Jenny
  • Riesbeck, Kristian
  • Lundin, Eva
  • Khaw, Kay‐Tee
  • Pérez Cornago, Aurora
  • Gunter, Marc J.
  • Dossus, Laure
  • Kaaks, Rudolf
  • Fortner, Renée T.
A substantial proportion of epithelial ovarian cancer (EOC) arises in the fallopian tube and other epithelia of the upper genital tract; these epithelia may incur damage and neoplastic transformation after sexually transmitted infections (STI) and pelvic inflammatory disease. We investigated the hypothesis that past STI infection, particularly Chlamydia trachomatis, is associated with higher EOC risk in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort including 791 cases and 1669 matched controls. Serum antibodies against C. trachomatis, Mycoplasma genitalium, herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) 16, 18 and 45 were assessed using multiplex fluorescent bead-based serology. Conditional logistic regression was used to estimate relative risks (RR) and 95% confidence intervals (CI) comparing women with positive vs. negative serology. A total of 40% of the study population was seropositive to at least one STI. Positive serology to C. trachomatis Pgp3 antibodies was not associated with EOC risk overall, but with higher risk of the mucinous histotype (RR = 2.30 [95% CI = 1.22-4.32]). Positive serology for chlamydia heat shock protein 60 (cHSP60-1) was associated with higher risk of EOC overall (1.36 [1.13-1.64]) and with the serous subtype (1.44 [1.12-1.85]). None of the other evaluated STIs were associated with EOC risk overall; however, HSV-2 was associated with higher risk of endometrioid EOC (2.35 [1.24-4.43]). The findings of our study suggest a potential role of C. trachomatis in the carcinogenesis of serous and mucinous EOC, while HSV-2 might promote the development of endometrioid disease.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study

  • Merritt, Melissa A.
  • Riboli, Elio
  • Murphy, Neil
  • Kadi, Mai
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Dossus, Laure
  • Dartois, Laureen
  • Clavel-Chapelon, Françoise
  • Fortner, Renée T.
  • Katzke, Verena
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Sieri, Sabina
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Lund, Eiliv
  • Nakamura, Aurelie
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Agudo, Antonio
  • Molina Montes, Esther
  • Larrañaga, Nerea
  • Dorronsoro, Miren
  • Cirera, Lluís
  • Barricarte, Aurelio
  • Olsson, Åsa
  • Butt, Salma Tunå
  • Idahl, Annika
  • Lundin, Eva
  • Wareham, Nicholas J.
  • Key, Timothy J.
  • Brennan, Paul
  • Ferrari, Pietro
  • Wark, Petra A.
  • Norat, Teresa
  • Cross, Amanda J.
  • Gunter, Marc J.
Background: Reproductive events are associated with important physiologic changes, yet little is known about how reproductive factors influence long-term health in women. Our objective was to assess the relation of reproductive characteristics with all-cause and cause-specific mortality risk. Methods: The analysis was performed within the European Investigation into Cancer and Nutrition prospective cohort study, which enrolled > 500,000 women and men from 1992 to 2000, who were residing in a given town/geographic area in 10 European countries. The current analysis included 322,972 eligible women aged 25-70 years with 99 % complete follow-up for vital status. We assessed reproductive characteristics reported at the study baseline including parity, age at the first birth, breastfeeding, infertility, oral contraceptive use, age at menarche and menopause, total ovulatory years, and history of oophorectomy/hysterectomy. Hazard ratios (HRs) and 95 % confidence intervals (CIs) for mortality were determined using Cox proportional hazards regression models adjusted for menopausal status, body mass index, physical activity, education level, and smoking status/intensity and duration. Results: During a mean follow-up of 12.9 years, 14,383 deaths occurred. The HR (95 % CI) for risk of all-cause mortality was lower in parous versus nulliparous women (0.80; 0.76-0.84), in women who had ever versus never breastfed (0.92; 0.87-0.97), in ever versus never users of oral contraceptives (among non-smokers; 0.90; 0.86-0.95), and in women reporting a later age at menarche (>= 15 years versus < 12; 0.90; 0.85-0.96; P for trend = 0.038). Conclusions: Childbirth, breastfeeding, oral contraceptive use, and a later age at menarche were associated with better health outcomes. These findings may contribute to the development of improved strategies to promote better long-term health in women.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  • Ward, Heather A.
  • Whitman, Julia
  • Muller, David C.
  • Johansson, Mattias
  • Jakszyn, Paula
  • Weiderpass, Elisabete
  • Palli, Domenico
  • Fanidi, Anouar
  • Vermeulen, Roel
  • Tjønneland, Anne
  • Hansen, Louise
  • Dahm, Christina C.
  • Overvad, Kim
  • Severi, Gianluca
  • Boutron-Ruault, Marie-Christine
  • Affret, Aurélie
  • Kaaks, Rudolf
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Kotanidou, Anastasia
  • Berrino, Franco
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Nøst, Therese Haugdahl
  • Sandanger, Torkjel M.
  • Quirós, José Ramón
  • Agudo, Antonio
  • Rodríguez Barranco, Miguel
  • Larrañaga, Nerea
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Drake, Isabel
  • Brunnström, Hans
  • Johansson, Mikael
  • Grankvist, Kjell
  • Travis, Ruth C.
  • Freisling, Heinz
  • Stepien, Magdalena
  • Merritt, Melissa A.
  • Riboli, Elio
  • Cross, Amanda J.
Background: Epidemiological studies suggest that haem iron, which is found predominantly in red meat and increases endogenous formation of carcinogenic N-nitroso compounds, may be positively associated with lung cancer. The objective was to examine the relationship between haem iron intake and lung cancer risk using detailed smoking history data and serum cotinine to control for potential confounding. Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC), 416,746 individuals from 10 countries completed demographic and dietary questionnaires at recruitment. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident lung cancer (n = 3731) risk relative to haem iron, non-haem iron, and total dietary iron intake. A corresponding analysis was conducted among a nested subset of 800 lung cancer cases and 1489 matched controls for whom serum cotinine was available. Results: Haem iron was associated with lung cancer risk, including after adjustment for details of smoking history (time since quitting, number of cigarettes per day): as a continuous variable (HR per 0.3 mg/1000 kcal 1.03, 95% CI 1.00-1.07), and in the highest versus lowest quintile (HR 1.16, 95% CI 1.02-1.32; trend across quintiles: P = 0.035). In contrast, non-haem iron intake was related inversely with lung cancer risk; however, this association attenuated after adjustment for smoking history. Additional adjustment for serum cotinine did not considerably alter the associations detected in the nested case-control subset. Conclusions: Greater haem iron intake may be modestly associated with lung cancer risk.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Circulating insulin-like growth factor I in relation to melanoma risk in the European Prospective Investigation into Cancer and Nutrition

  • Bradbury, Kathryn E.
  • Appleby, Paul N.
  • Tipper, Sarah J.
  • Travis, Ruth C.
  • Allen, Naomi E.
  • Kvaskoff, Marina
  • Overvad, Kim
  • Tjønneland, Anne
  • Halkjær, Jytte
  • Cervenka, Iris
  • Mahamat-Saleh, Yahya
  • Bonnet, Fabrice
  • Kaaks, Rudolf
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Stratigos, Alexander J.
  • Palli, Domenico
  • Grioni, Sara
  • Matullo, Giuseppe
  • Panico, Salvatore
  • Tumino, Rosario
  • Peeters, Petra H. M.
  • Bueno de Mesquita, H. Bas
  • Ghiasvand, Reza
  • Veierød, Marit B.
  • Weiderpass, Elisabete
  • Bonet Bonet, Catalina
  • Molina, Elena
  • Huerta Castaño, José María
  • Larrañaga, Nerea
  • Barricarte, Aurelio
  • Merino, Susana
  • Isaksson, Karolin
  • Stocks, Tanja
  • Ljuslinder, Ingrid
  • Hemmingsson, Oskar
  • Wareham, Nick
  • Khaw, Kay‐Tee
  • Gunter, Marc J.
  • Rinaldi, Sabina
  • Tsilidis, Konstantinos K.
  • Aune, Dagfinn
  • Riboli, Elio
  • Key, Timothy J.
Insulin-like growth factor-I (IGF-I) regulates cell proliferation and apoptosis, and is thought to play a role in tumour development. Previous prospective studies have shown that higher circulating concentrations of IGF-I are associated with a higher risk of cancers at specific sites, including breast and prostate. No prospective study has examined the association between circulating IGF-I concentrations and melanoma risk. A nested case-control study of 1,221 melanoma cases and 1,221 controls was performed in the European Prospective Investigation into Cancer and Nutrition cohort, a prospective cohort of 520,000 participants recruited from 10 European countries. Conditional logistic regression was used to estimate odds ratios (ORs) for incident melanoma in relation to circulating IGF-I concentrations, measured by immunoassay. Analyses were conditioned on the matching factors and further adjusted for age at blood collection, education, height, BMI, smoking status, alcohol intake, marital status, physical activity and in women only, use of menopausal hormone therapy. There was no significant association between circulating IGF-I concentration and melanoma risk (OR for highest vs lowest fifth = 0.93 [95% confidence interval [CI]: 0.71 to 1.22]). There was no significant heterogeneity in the association between IGF-I concentrations and melanoma risk when subdivided by gender, age at blood collection, BMI, height, age at diagnosis, time between blood collection and diagnosis, or by anatomical site or histological subtype of the tumour (Pheterogeneity≥0.078). We found no evidence for an association between circulating concentrations of IGF-I measured in adulthood and the risk of melanoma.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

  • Castellví Bel, Sergi
  • Moreno Aguado, Víctor
Background: Higher adiposity increases the risk of colorectal cancer (CRC), but whether this relationship varies by anatomical sub-site or by sex is unclear. Further, the metabolic alterations mediating the effects of adiposity on CRC are not fully understood. Methods: We examined sex- and site-specific associations of adiposity with CRC risk and whether adiposity-associated metabolites explain the associations of adiposity with CRC. Genetic variants from genome-wide association studies of body mass index (BMI) and waist-to-hip ratio (WHR, unadjusted for BMI; N = 806,810), and 123 metabolites from targeted nuclear magnetic resonance metabolomics (N = 24,925), were used as instruments. Sex-combined and sex-specific Mendelian randomization (MR) was conducted for BMI and WHR with CRC risk (58,221 cases and 67,694 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry). Sex-combined MR was conducted for BMI and WHR with metabolites, for metabolites with CRC, and for BMI and WHR with CRC adjusted for metabolite classes in multivariable models. Results: In sex-specific MR analyses, higher BMI (per 4.2 kg/m2) was associated with 1.23 (95% confidence interval (CI) = 1.08, 1.38) times higher CRC odds among men (inverse-variance-weighted (IVW) model); among women, higher BMI (per 5.2 kg/m2) was associated with 1.09 (95% CI = 0.97, 1.22) times higher CRC odds. WHR (per 0.07 higher) was more strongly associated with CRC risk among women (IVW OR = 1.25, 95% CI = 1.08, 1.43) than men (IVW OR = 1.05, 95% CI = 0.81, 1.36). BMI or WHR was associated with 104/123 metabolites at false discovery rate-corrected P ≤ 0.05; several metabolites were associated with CRC, but not in directions that were consistent with the mediation of positive adiposity-CRC relations. In multivariable MR analyses, associations of BMI and WHR with CRC were not attenuated following adjustment for representative metabolite classes, e.g., the univariable IVW OR for BMI with CRC was 1.12 (95% CI = 1.00, 1.26), and this became 1.11 (95% CI = 0.99, 1.26) when adjusting for cholesterol in low-density lipoprotein particles. Conclusions: Our results suggest that higher BMI more greatly raises CRC risk among men, whereas higher WHR more greatly raises CRC risk among women. Adiposity was associated with numerous metabolic alterations, but none of these explained associations between adiposity and CRC. More detailed metabolomic measures are likely needed to clarify the mechanistic pathways.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Prospective analysis of circulating metabolites and breast cancer in EPIC

  • His, Mathilde
  • Viallon, Vivian
  • Dossus, Laure
  • Gicquiau, Audrey
  • Achaintre, David
  • Scalbert, Augustin
  • Ferrari, Pietro
  • Romieu, Isabelle
  • Onland-Moret, N. Charlotte
  • Weiderpass, Elisabete
  • Dahm, Christina C.
  • Overvad, Kim
  • Olsen, Anja
  • Tjønneland, Anne
  • Fournier, Agnès
  • Rothwell, Joseph A.
  • Severi, Gianluca
  • Kühn, Tilman
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Martimianaki, Georgia
  • Masala, Giovanna
  • Sieri, Sabina
  • Tumino, Rosario
  • Vineis, Paolo
  • Panico, Salvatore
  • van Gils, Carla H.
  • Nøst, Therese Haugdahl
  • Sandanger, Torkjel M.
  • Skeie, Guri
  • Quirós, José Ramón
  • Agudo, Antonio
  • Sánchez, María José
  • Amiano, Pilar
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Schmidt, Julie A.
  • Travis, Ruth C.
  • Riboli, Elio
  • Tsilidis, Konstantinos K.
  • Christakoudi, Sofia
  • Gunter, Marc J.
  • Rinaldi, Sabina
Background: Metabolomics is a promising molecular tool to identify novel etiologic pathways leading to cancer. Using a targeted approach, we prospectively investigated the associations between metabolite concentrations in plasma and breast cancer risk. Methods: A nested case-control study was established within the European Prospective Investigation into Cancer cohort, which included 1624 first primary incident invasive breast cancer cases (with known estrogen and progesterone receptor and HER2 status) and 1624 matched controls. Metabolites (n = 127, acylcarnitines, amino acids, biogenic amines, glycerophospholipids, hexose, sphingolipids) were measured by mass spectrometry in pre-diagnostic plasma samples and tested for associations with breast cancer incidence using multivariable conditional logistic regression. Results: Among women not using hormones at baseline (n = 2248), and after control for multiple tests, concentrations of arginine (odds ratio [OR] per SD = 0.79, 95% confidence interval [CI] = 0.70-0.90), asparagine (OR = 0.83 (0.74-0.92)), and phosphatidylcholines (PCs) ae C36:3 (OR = 0.83 (0.76-0.90)), aa C36:3 (OR = 0.84 (0.77-0.93)), ae C34:2 (OR = 0.85 (0.78-0.94)), ae C36:2 (OR = 0.85 (0.78-0.88)), and ae C38:2 (OR = 0.84 (0.76-0.93)) were inversely associated with breast cancer risk, while the acylcarnitine C2 (OR = 1.23 (1.11-1.35)) was positively associated with disease risk. In the overall population, C2 (OR = 1.15 (1.06-1.24)) and PC ae C36:3 (OR = 0.88 (0.82-0.95)) were associated with risk of breast cancer, and these relationships did not differ by breast cancer subtype, age at diagnosis, fasting status, menopausal status, or adiposity. Conclusions: These findings point to potentially novel pathways and biomarkers of breast cancer development. Results warrant replication in other epidemiological studies.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

  • Lin, Crystal
  • Travis, Ruth C.
  • Appleby, Paul N.
  • Tipper, Sarah
  • Weiderpass, Elisabete
  • Chang Claude, Jenny
  • Gram, Inger T.
  • Kaaks, Rudolf
  • Kiemeney, Lambertus A. L. M.
  • Ljungberg, Börje
  • Tumino, Rosario
  • Tjønneland, Anne
  • Roswall, Nina
  • Overvad, Kim
  • Boutron-Ruault, Marie-Christine
  • Manciniveri, Francesca Romana
  • Severi, Gianluca
  • Trichopoulou, Antonia
  • Masala, Giovanna
  • Sacerdote, Carlotta
  • Agnoli, Claudia
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Salamanca Fernández, Elena
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Menéndez, Virginia
  • Luján Barroso, Leila
  • Liedberg, Fredrik
  • Freisling, Heinz
  • Gunter, Marc J.
  • Aune, Dagfinn
  • Cross, Amanda J.
  • Riboli, Elio
  • Key, Timothy J.
  • Pérez Cornago, Aurora
Previous in vitro and case-control studies have found an association between the insulin-like growth factor (IGF)-axis and bladder cancer risk. Circulating concentrations of IGF-I have also been found to be associated with an increased risk of several cancer types; however, the relationship between pre-diagnostic circulating IGF-I concentrations and bladder cancer has never been studied prospectively. We investigated the association of pre-diagnostic plasma concentrations of IGF-I with risk of overall bladder cancer and urothelial cell carcinoma (UCC) in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 843 men and women diagnosed with bladder cancer between 1992 and 2005 were matched with 843 controls by recruitment centre, sex, age at recruitment, date of blood collection, duration of follow-up, time of day and fasting status at blood collection using an incidence density sampling protocol. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression with adjustment for smoking status. No association was found between pre-diagnostic circulating IGF-I concentration and overall bladder cancer risk (adjusted OR for highest versus lowest fourth: 0.91, 95% CI: 0.66-1.24, ptrend = 0.40) or UCC (n of cases = 776; 0.91, 0.65-1.26, ptrend = 0.40). There was no significant evidence of heterogeneity in the association of IGF-I with bladder cancer risk by tumour aggressiveness, sex, smoking status, or by time between blood collection and diagnosis (pheterogeneity > 0.05 for all). This first prospective study indicates no evidence of an association between plasma IGF-I concentrations and bladder cancer risk.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort

  • Fages, Anne
  • Duarte Salles, Talita
  • Stepien, Magdalena
  • Ferrari, Pietro
  • Fedirko, Veronika
  • Pontoizeau, Clément
  • Trichopoulou, Antonia
  • Aleksandrova, Krasimira
  • Tjønneland, Anne
  • Olsen, Anja
  • Clavel-Chapelon, Françoise
  • Boutron-Ruault, Marie-Christine
  • Severi, Gianluca
  • Kaaks, Rudolf
  • Kuhn, Tilman
  • Floegel, Anna
  • Boeing, Heiner
  • Lagiou, Pagona
  • Bamia, Christina
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Pala, Valeria
  • Panico, Salvatore
  • Tumino, Rosario
  • Vineis, Paolo
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Agudo, Antonio
  • Molina Montes, Esther
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Sjöberg, Klas
  • Ohlsson, Bodil
  • Khaw, Kay-Tee
  • Wareham, Nicholas J.
  • Travis, Ruth C.
  • Schmidt, Julie A.
  • Cross, Amanda J.
  • Gunter, Marc J.
  • Riboli, Elio
  • Scalbert, Augustin
  • Romieu, Isabelle
  • Elena-Herrmann, Benedicte
  • Jenab, Mazda
Background: Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers. Methods: To address these aspects, an untargeted nuclear magnetic resonance metabolomic approach was applied to pre-diagnostic serum samples obtained from first incident, primary HCC cases (n = 114) and matched controls (n = 222) identified from amongst the participants of a large European prospective cohort. Results: A metabolic pattern associated with HCC risk comprised of perturbations in fatty acid oxidation and amino acid, lipid, and carbohydrate metabolism was observed. Sixteen metabolites of either endogenous or exogenous origin were found to be significantly associated with HCC risk. The influence of hepatitis infection and potential liver damage was assessed, and further analyses were made to distinguish patterns of early or later diagnosis. Conclusion: Our results show clear metabolic alterations from early stages of HCC development with application for better etiologic understanding, prevention, and early detection of this increasingly common cancer.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  • Assi, Nada
  • Moskal, Aurelie
  • Slimani, Nadia
  • Viallon, Vivian
  • Chajès, Véronique
  • Freisling, Heinz
  • Monni, Stefano
  • Knüppel, Sven
  • Förster, Jana
  • Weiderpass, Elisabete
  • Luján Barroso, Leila
  • Amiano, Pilar
  • Ardanaz, Eva
  • Molina Montes, Esther
  • Salmerón, Diego
  • Quirós, José Ramón
  • Olsen, Anja
  • Tjønneland, Anne
  • Dahm, Christina C.
  • Overvad, Kim
  • Dossus, Laure
  • Fournier, Agnès
  • Baglietto, Laura
  • Fortner, Renée T.
  • Kaaks, Rudolf
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Santucci de Magistris, Maria
  • Masala, Giovanna
  • Agnoli, Claudia
  • Ricceri, Fulvio
  • Tumino, Rosario
  • Bueno de Mesquita, H. Bas
  • Bakker, Marije F.
  • Peeters, Petra H. M.
  • Skeie, Guri
  • Braaten, Tonje
  • Winkvist, Anna
  • Johansson, Ingegerd
Objective: Pattern analysis has emerged as a tool to depict the role of multiple nutrients/foods in relation to health outcomes. The present study aimed at extracting nutrient patterns with respect to breast cancer (BC) aetiology. Design: Nutrient patterns were derived with treelet transform (TT) and related to BC risk. TT was applied to twenty-three log-transformed nutrient densities from dietary questionnaires. Hazard ratios (HR) and 95 % confidence intervals computed using Cox proportional hazards models quantified the association between quintiles of nutrient pattern scores and risk of overall BC, and by hormonal receptor and menopausal status. Principal component analysis was applied for comparison. Setting: The European Prospective Investigation into Cancer and Nutrition (EPIC). Subjects: Women (n 334 850) from the EPIC study. Results: The first TT component (TC1) highlighted a pattern rich in nutrients found in animal foods loading on cholesterol, protein, retinol, vitamins B12 and D, while the second TT component (TC2) reflected a diet rich in β-carotene, riboflavin, thiamin, vitamins C and B6, fibre, Fe, Ca, K, Mg, P and folate. While TC1 was not associated with BC risk, TC2 was inversely associated with BC risk overall (HRQ5 v. Q1=0·89, 95 % CI 0·83, 0·95, Ptrend<0·01) and showed a significantly lower risk in oestrogen receptor-positive (HRQ5 v. Q1=0·89, 95 % CI 0·81, 0·98, Ptrend=0·02) and progesterone receptor-positive tumours (HRQ5 v. Q1=0·87, 95 % CI 0·77, 0·98, Ptrend<0·01). Conclusions: TT produces readily interpretable sparse components explaining similar amounts of variation as principal component analysis. Our results suggest that participants with a nutrient pattern high in micronutrients found in vegetables, fruits and cereals had a lower risk of BC.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study

  • Ritte, Rebecca
  • Tikk, Kaja
  • Lukanova, Annekatrin
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Dossus, Laure
  • Fournier, Agnès
  • Clavel-Chapelon, Françoise
  • Grote, Verena A.
  • Boeing, Heiner
  • Aleksandrova, Krasimira
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Berrino, Franco
  • Mattiello, Amalia
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Quirós, José Ramón
  • Buckland, Genevieve
  • Molina Montes, Esther
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Amiano, Pilar
  • Bueno de Mesquita, H. Bas
  • van Gils, Carla H.
  • Peeters, Petra H. M.
  • Wareham, Nicholas J.
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Travis, Ruth C.
  • Weiderpass, Elisabete
  • Dumeaux, Vanessa
  • Lund, Eiliv
  • Sund, Malin
  • Andersson, Anne
  • Romieu, Isabelle
  • Rinaldi, Sabina
  • Vineis, Paolo
  • Merritt, Melissa A.
  • Riboli, Elio
  • Kaaks, Rudolf
Background: The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain. Methods: Within the EPIC cohort, Cox proportional hazards models were used to describe the relationships of reproductive factors (menarcheal age, time between menarche and first pregnancy, parity, number of children, age at first and last pregnancies, time since last full-term childbirth, breastfeeding, age at menopause, ever having an abortion and use of oral contraceptives [OC]) with risk of ER-PR-(n = 998) and ER+PR+ (n = 3,567) breast tumors. Results: A later first full-term childbirth was associated with increased risk of ER+PR+ tumors but not with risk of ER-PR-tumors (= 35 vs. = 19 years HR: 1.47 [95% CI 1.15-1.88] p(trend) < 0.001 for ER+PR+ tumors; = 35 vs. = 19 years HR: 0.93 [95% CI 0.53-1.65] p(trend) = 0.96 for ER-PR-tumors; P-het = 0.03). The risk associations of menarcheal age, and time period between menarche and first full-term childbirth with ER-PR-tumors were in the similar direction with risk of ER+PR+ tumors (p(het) = 0.50), although weaker in magnitude and statistically only borderline significant. Other parity related factors such as ever a full-term birth, number of births, age-and time since last birth were associated only with ER+PR+ malignancies, however no statistical heterogeneity between breast cancer subtypes was observed. Breastfeeding and OC use were generally not associated with breast cancer subtype risk. Conclusion: Our study provides possible evidence that age at menarche, and time between menarche and first full-term childbirth may be associated with the etiology of both HR-negative and HR-positive malignancies, although the associations with HR-negative breast cancer were only borderline significant.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A Body Shape Index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort

  • Christakoudi, Sofia
  • Tsilidis, Konstantinos K.
  • Muller, David C.
  • Freisling, Heinz
  • Weiderpass, Elisabete
  • Overvad, Kim
  • Soderberg, Stefan
  • Haggstrom, Christel
  • Pischon, Tobias
  • Dahm, Christina C.
  • Zhang, Jie
  • Tjønneland, Anne
  • Halkjær, Jytte
  • MacDonald, Conor
  • Boutron-Ruault, Marie-Christine
  • Mancini, Francesca Romana
  • Kühn, Tilman
  • Kaaks, Rudolf
  • Schulze, Matthias B.
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Peppa, Eleni
  • Masala, Giovanna
  • Pala, Valeria
  • Panico, Salvatore
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Quirós, José Ramón
  • Agudo, Antonio
  • Sánchez, María José
  • Cirera, Lluís
  • Barricarte, Aurelio
  • Amiano, Pilar
  • Memarian, Ensieh
  • Sonestedt, Emily
  • Bueno de Mesquita, H. Bas
  • May, Anne M.
  • Khaw, Kay‑Tee
  • Wareham, Nicholas J.
  • Tong, Tammy Y. N.
  • Huybrechts, Inge
  • Noh, Hwayoung
  • Aglago, Elom K.
  • Ellingjord-Dale, Merete
  • Ward, Heather A.
  • Aune, Dagfinn
  • Riboli, Elio
Abdominal and general adiposity are independently associated with mortality, but there is no consensus on how best to assess abdominal adiposity. We compared the ability of alternative waist indices to complement body mass index (BMI) when assessing all-cause mortality. We used data from 352,985 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) and Cox proportional hazards models adjusted for other risk factors. During a mean follow-up of 16.1 years, 38,178 participants died. Combining in one model BMI and a strongly correlated waist index altered the association patterns with mortality, to a predominantly negative association for BMI and a stronger positive association for the waist index, while combining BMI with the uncorrelated A Body Shape Index (ABSI) preserved the association patterns. Sex-specific cohort-wide quartiles of waist indices correlated with BMI could not separate high-risk from low-risk individuals within underweight (BMI<18.5 kg/m(2)) or obese (BMI<greater than or equal to>30 kg/m(2)) categories, while the highest quartile of ABSI separated 18-39% of the individuals within each BMI category, which had 22-55% higher risk of death. In conclusion, only a waist index independent of BMI by design, such as ABSI, complements BMI and enables efficient risk stratification, which could facilitate personalisation of screening, treatment and monitoring.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

  • Fortner, Renée T.
  • Vitonis, Allison F.
  • Schock, Helena
  • Hüsing, Anika
  • Johnson, Theron
  • Fichorova, Raina N.
  • Fashemi, Titilayo
  • Yamamoto, Hidemi S.
  • Tjønneland, Anne
  • Hansen, Louise
  • Overvad, Kim
  • Boutron-Ruault, Marie-Christine
  • Kvaskoff, Marina
  • Severi, Gianluca
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Benetou, Vassiliki
  • Vecchia, Carlo La
  • Palli, Domenico
  • Sieri, Sabina
  • Tumino, Rosario
  • Matullo, Giuseppe
  • Mattiello, Amalia
  • Onland-Moret, N. Charlotte
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Gram, Inger T.
  • Jareid, Mie
  • Quirós, José Ramón
  • Duell, Eric J.
  • Sánchez, María José
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Larrañaga, Nerea
  • Nodin, Björn
  • Brandstedt, Jenny
  • Idahl, Annika
  • Khaw, Kay-Tee
  • Allen, Naomi E.
  • Gunter, Marc J.
  • Johansson, Mattias
  • Dossus, Laure
  • Merritt, Melissa A.
  • Riboli, Elio
  • Cramer, Daniel W.
  • Kaaks, Rudolf
  • Terry, Kathryn L.
Background: Ovarian cancer early detection markers CA125, CA15.3, HE4, and CA72.4 vary between healthy women, limiting their utility for screening. Methods: We evaluated cross-sectional relationships between lifestyle and reproductive factors and these markers among controls (n = 1910) from a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Improvements in discrimination of prediction models adjusting for correlates of the markers were evaluated among postmenopausal women in the nested case-control study (n = 590 cases). Generalized linear models were used to calculate geometric means of CA125, CA15.3, and HE4. CA72.4 above vs. below limit of detection was evaluated using logistic regression. Early detection prediction was modeled using conditional logistic regression. Results: CA125 concentrations were lower, and CA15.3 higher, in post-vs. premenopausal women (p <= 0.02). Among postmenopausal women, CA125 was higher among women with higher parity and older age at menopause (p(trend) <= 0. 02), but lower among women reporting oophorectomy, hysterectomy, ever use of estrogen-only hormone therapy, or current smoking (p < 0.01). CA15.3 concentrations were higher among heavier women and in former smokers (p <= 0.03). HE4 was higher with older age at blood collection and in current smokers, and inversely associated with OC use duration, parity, and older age at menopause (<= 0.02). No associations were observed with CA72.4. Adjusting for correlates of the markers in prediction models did not improve the discrimination. Conclusions: This study provides insights into sources of variation in ovarian cancer early detection markers in healthy women and informs about the utility of individualizing marker cutpoints based on epidemiologic factors.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Plasma polyphenols associated with lower high-sensitivity C-reactive protein concentrations: a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  • Harms, Laura M.
  • Scalbert, Augustin
  • Zamora-Ros, Raul
  • Rinaldi, Sabina
  • Jenab, Mazda
  • Murphy, Neil
  • Achaintre, David
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Mancini, Francesca Romana
  • Mahamat-Saleh, Yahya
  • Boutron-Ruault, Marie-Christine
  • Kühn, Tilman
  • Katzke, Verena
  • Trichopoulou, Antonia
  • Martimianaki, Georgia
  • Karakatsani, Anna
  • Palli, Domenico
  • Panico, Salvatore
  • Sieri, Sabina
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Bueno de Mesquita, H. Bas
  • Vermeulen, Roel C. H.
  • Weiderpass, Elisabete
  • Haugdahl Nøst, Therese
  • Lasheras, Cristina
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Barricarte, Aurelio
  • Dorronsoro, Miren
  • Hultdin, Johan
  • Schmidt, Julie A.
  • Gunter, Marc J.
  • Riboli, Elio
  • Aleksandrova, Krasimira
Experimental studies have reported on the anti-inflammatory properties of polyphenols. However, results from epidemiological investigations have been inconsistent and especially studies using biomarkers for assessment of polyphenol intake have been scant. We aimed to characterise the association between plasma concentrations of thirty-five polyphenol compounds and low-grade systemic inflammation state as measured by high-sensitivity C-reactive protein (hsCRP). A cross-sectional data analysis was performed based on 315 participants in the European Prospective Investigation into Cancer and Nutrition cohort with available measurements of plasma polyphenols and hsCRP. In logistic regression analysis, the OR and 95 % CI of elevated serum hsCRP (>3 mg/l) were calculated within quartiles and per standard deviation higher level of plasma polyphenol concentrations. In a multivariable-adjusted model, the sum of plasma concentrations of all polyphenols measured (per standard deviation) was associated with 29 (95 % CI 50, 1) % lower odds of elevated hsCRP. In the class of flavonoids, daidzein was inversely associated with elevated hsCRP (OR 0 center dot 66, 95 % CI 0 center dot 46, 0 center dot 96). Among phenolic acids, statistically significant associations were observed for 3,5-dihydroxyphenylpropionic acid (OR 0 center dot 58, 95 % CI 0 center dot 39, 0 center dot 86), 3,4-dihydroxyphenylpropionic acid (OR 0 center dot 63, 95 % CI 0 center dot 46, 0 center dot 87), ferulic acid (OR 0 center dot 65, 95 % CI 0 center dot 44, 0 center dot 96) and caffeic acid (OR 0 center dot 69, 95 % CI 0 center dot 51, 0 center dot 93). The odds of elevated hsCRP were significantly reduced for hydroxytyrosol (OR 0 center dot 67, 95 % CI 0 center dot 48, 0 center dot 93). The present study showed that polyphenol biomarkers are associated with lower odds of elevated hsCRP. Whether diet rich in bioactive polyphenol compounds could be an effective strategy to prevent or modulate deleterious health effects of inflammation should be addressed by further well-powered longitudinal studies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Comparison of prognostic models to predict the occurrence of colorectal cancer in asymptomatic individuals: a systematic literature review and external validation in the EPIC and UK Biobank prospective cohort studies

  • Smith, Todd
  • Muller, David C.
  • Moons, Karel G. M.
  • Cross, Amanda J.
  • Johansson, Mattias
  • Ferrari, Pietro
  • Fagherazzi, Guy
  • Peeters, Petra H. M.
  • Severi, Gianluca
  • Hüsing, Anika
  • Kaaks, Rudolf
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Bonet Bonet, Catalina
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Barricarte, Aurelio
  • Bradbury, Kathryn E.
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Palli, Domenico
  • Pala, Valeria
  • Vineis, Paolo
  • Bueno de Mesquita, H. Bas
  • Ohlsson, Bodil
  • Harlid, Sophia
  • Van Guelpen, Bethany
  • Skeie, Guri
  • Weiderpass, Elisabete
  • Jenab, Mazda
  • Murphy, Neil
  • Riboli, Elio
  • Gunter, Marc J.
  • Aleksandrova, Krasimira
  • Tzoulaki, Ioanna
Objective: To systematically identify and validate published colorectal cancer risk prediction models that do not require invasive testing in two large population-based prospective cohorts. Design: Models were identified through an update of a published systematic review and validated in the European Prospective Investigation into Cancer and Nutrition (EPIC) and the UK Biobank. The performance of the models to predict the occurrence of colorectal cancer within 5 or 10 years after study enrolment was assessed by discrimination (C-statistic) and calibration (plots of observed vs predicted probability). Results: The systematic review and its update identified 16 models from 8 publications (8 colorectal, 5 colon and 3 rectal). The number of participants included in each model validation ranged from 41 587 to 396 515, and the number of cases ranged from 115 to 1781. Eligible and ineligible participants across the models were largely comparable. Calibration of the models, where assessable, was very good and further improved by recalibration. The C-statistics of the models were largely similar between validation cohorts with the highest values achieved being 0.70 (95% CI 0.68 to 0.72) in the UK Biobank and 0.71 (95% CI 0.67 to 0.74) in EPIC. Conclusion: Several of these non-invasive models exhibited good calibration and discrimination within both external validation populations and are therefore potentially suitable candidates for the facilitation of risk stratification in population-based colorectal screening programmes. Future work should both evaluate this potential, through modelling and impact studies, and ascertain if further enhancement in their performance can be obtained.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts

  • Li, Kuanrong
  • Anderson, Garnet
  • Viallon, Vivian
  • Arveux, Patrick
  • Kvaskoff, Marina
  • Fournier, Agnès
  • Krogh, Vittorio
  • Tumino, Rosario
  • Sánchez, María José
  • Ardanaz, Eva
  • Chirlaque, María Dolores
  • Agudo, Antonio
  • Muller, David C.
  • Smith, Todd
  • Tzoulaki, Ioanna
  • Key, Timothy J.
  • Bueno de Mesquita, H. Bas
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Kaaks, Rudolf
  • Hüsing, Anika
  • Fortner, Renée T.
  • Zeleniuch-Jacquotte, Anne
  • Sund, Malin
  • Dahm, Christina C.
  • Overvad, Kim
  • Aune, Dagfinn
  • Weiderpass, Elisabete
  • Romieu, Isabelle
  • Riboli, Elio
  • Gunter, Marc J.
  • Dossus, Laure
  • Prentice, Ross L.
  • Ferrari, Pietro
Background: Few published breast cancer (BC) risk prediction models consider the heterogeneity of predictor variables between estrogen-receptor positive (ER+) and negative (ER-) tumors. Using data from two large cohorts, we examined whether modeling this heterogeneity could improve prediction. Methods: We built two models, for ER+ (ModelER+) and ER- tumors (ModelER-), respectively, in 281,330 women (51% postmenopausal at recruitment) from the European Prospective Investigation into Cancer and Nutrition cohort. Discrimination (C-statistic) and calibration (the agreement between predicted and observed tumor risks) were assessed both internally and externally in 82,319 postmenopausal women from the Women’s Health Initiative study. We performed decision curve analysis to compare ModelER+ and the Gail model (ModelGail) regarding their applicability in risk assessment for chemoprevention. Results: Parity, number of full-term pregnancies, age at first full-term pregnancy and body height were only associated with ER+ tumors. Menopausal status, age at menarche and at menopause, hormone replacement therapy, postmenopausal body mass index, and alcohol intake were homogeneously associated with ER+ and ER- tumors. Internal validation yielded a C-statistic of 0.64 for ModelER+ and 0.59 for ModelER-. External validation reduced the C-statistic of ModelER+ (0.59) and ModelGail (0.57). In external evaluation of calibration, ModelER+ outperformed the ModelGail: the former led to a 9% overestimation of the risk of ER+ tumors, while the latter yielded a 22% underestimation of the overall BC risk. Compared with the treat-all strategy, ModelER+ produced equal or higher net benefits irrespective of the benefit-to-harm ratio of chemoprevention, while ModelGail did not produce higher net benefits unless the benefit-to-harm ratio was below 50. The clinical applicability, i.e. the area defined by the net benefit curve and the treat-all and treat-none strategies, was 12.7 × 10− 6 for ModelER+ and 3.0 × 10− 6 for ModelGail. Conclusions: Modeling heterogeneous epidemiological risk factors might yield little improvement in BC risk prediction. Nevertheless, a model specifically predictive of ER+ tumor risk could be more applicable than an omnibus model in risk assessment for chemoprevention.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Circulating Metabolites Associated With Alcohol Intake In The European Prospective Investigation Into Cancer And Nutrition Cohort

  • Van Roekel, Eline H.
  • Trijsburg, Laura
  • Assi, Nada
  • Carayol, Marion
  • Achaintre, David
  • Murphy, Neil
  • Rinaldi, Sabina
  • Schmidt, Julie A.
  • Stepien, Magdalena
  • Kaaks, Rudolf
  • Kuhn, Tilman
  • Boeing, Heiner
  • Iqbal, Khalid
  • Palli, Domenico
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Panico, Salvatore
  • Peeters, Petra H. M.
  • Bueno de Mesquita, H. Bas
  • Ardanaz, Eva
  • Luján Barroso, Leila
  • Quirós, José Ramón
  • Huerta Castaño, José María
  • Molina Portillo, Elena
  • Dorronsoro, Miren
  • Tsilidis, Konstantinos K.
  • Riboli, Elio
  • Rostgaard-Hansen, Agnetha Linn
  • Tjønneland, Anne
  • Overvad, Kim
  • Weiderpass, Elisabete
  • Boutron-Ruault, Marie-Christine
  • Severi, Gianluca
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Kotanidou, Anastasia
  • Hakänsson, Anders
  • Malm, Johan
  • Weijenberg, Matty P.
  • Gunter, Marc J.
  • Jenab, Mazda
  • Johansson, Mattias
  • Travis, Ruth C.
  • Scalbert, Augustin
  • Ferrari, Pietro
Identifying the metabolites associated with alcohol consumption may provide insights into the metabolic pathways through which alcohol may affect human health. We studied associations of alcohol consumption with circulating concentrations of 123 metabolites among 2974 healthy participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Alcohol consumption at recruitment was self-reported through dietary questionnaires. Metabolite concentrations were measured by tandem mass spectrometry (BIOCRATES AbsoluteIDQTM p180 kit). Data were randomly divided into discovery (2/3) and replication (1/3) sets. Multivariable linear regression models were used to evaluate confounder-adjusted associations of alcohol consumption with metabolite concentrations. Metabolites significantly related to alcohol intake in the discovery set (FDR q-value < 0.05) were further tested in the replication set (Bonferroni-corrected p-value < 0.05). Of the 72 metabolites significantly related to alcohol intake in the discovery set, 34 were also significant in the replication analysis, including three acylcarnitines, the amino acid citrulline, four lysophosphatidylcholines, 13 diacylphosphatidylcholines, seven acyl-alkylphosphatidylcholines, and six sphingomyelins. Our results confirmed earlier findings that alcohol consumption was associated with several lipid metabolites, and possibly also with specific acylcarnitines and amino acids. This provides further leads for future research studies aiming at elucidating the mechanisms underlying the effects of alcohol in relation to morbid conditions.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

  • Lin, Crystal
  • Travis, Ruth C.
  • Appleby, Paul N.
  • Tipper, Sarah
  • Weiderpass, Elisabete
  • Chang Claude, Jenny
  • Gram, Inger T.
  • Kaaks, Rudolf
  • Kiemeney, Lambertus A. L. M.
  • Ljungberg, Börje
  • Tumino, Rosario
  • Tjønneland, Anne
  • Roswall, Nina
  • Overvad, Kim
  • Boutron-Ruault, Marie-Christine
  • Manciniveri, Francesca Romana
  • Severi, Gianluca
  • Trichopoulou, Antonia
  • Masala, Giovanna
  • Sacerdote, Carlotta
  • Agnoli, Claudia
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Salamanca Fernández, Elena
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Menéndez, Virginia
  • Luján Barroso, Leila
  • Liedberg, Fredrik
  • Freisling, Heinz
  • Gunter, Marc J.
  • Aune, Dagfinn
  • Cross, Amanda J.
  • Riboli, Elio
  • Key, Timothy J.
  • Pérez Cornago, Aurora
Previous in vitro and case-control studies have found an association between the insulin-like growth factor (IGF)-axis and bladder cancer risk. Circulating concentrations of IGF-I have also been found to be associated with an increased risk of several cancer types; however, the relationship between pre-diagnostic circulating IGF-I concentrations and bladder cancer has never been studied prospectively. We investigated the association of pre-diagnostic plasma concentrations of IGF-I with risk of overall bladder cancer and urothelial cell carcinoma (UCC) in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 843 men and women diagnosed with bladder cancer between 1992 and 2005 were matched with 843 controls by recruitment centre, sex, age at recruitment, date of blood collection, duration of follow-up, time of day and fasting status at blood collection using an incidence density sampling protocol. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression with adjustment for smoking status. No association was found between pre-diagnostic circulating IGF-I concentration and overall bladder cancer risk (adjusted OR for highest versus lowest fourth: 0.91, 95% CI: 0.66-1.24, ptrend = 0.40) or UCC (n of cases = 776; 0.91, 0.65-1.26, ptrend = 0.40). There was no significant evidence of heterogeneity in the association of IGF-I with bladder cancer risk by tumour aggressiveness, sex, smoking status, or by time between blood collection and diagnosis (pheterogeneity > 0.05 for all). This first prospective study indicates no evidence of an association between plasma IGF-I concentrations and bladder cancer risk.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort

  • Fages, Anne
  • Duarte Salles, Talita
  • Stepien, Magdalena
  • Ferrari, Pietro
  • Fedirko, Veronika
  • Pontoizeau, Clément
  • Trichopoulou, Antonia
  • Aleksandrova, Krasimira
  • Tjønneland, Anne
  • Olsen, Anja
  • Clavel-Chapelon, Françoise
  • Boutron-Ruault, Marie-Christine
  • Severi, Gianluca
  • Kaaks, Rudolf
  • Kuhn, Tilman
  • Floegel, Anna
  • Boeing, Heiner
  • Lagiou, Pagona
  • Bamia, Christina
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Pala, Valeria
  • Panico, Salvatore
  • Tumino, Rosario
  • Vineis, Paolo
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Agudo, Antonio
  • Molina Montes, Esther
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Dorronsoro, Miren
  • Sjöberg, Klas
  • Ohlsson, Bodil
  • Khaw, Kay-Tee
  • Wareham, Nicholas J.
  • Travis, Ruth C.
  • Schmidt, Julie A.
  • Cross, Amanda J.
  • Gunter, Marc J.
  • Riboli, Elio
  • Scalbert, Augustin
  • Romieu, Isabelle
  • Elena-Herrmann, Benedicte
  • Jenab, Mazda
Background: Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers. Methods: To address these aspects, an untargeted nuclear magnetic resonance metabolomic approach was applied to pre-diagnostic serum samples obtained from first incident, primary HCC cases (n = 114) and matched controls (n = 222) identified from amongst the participants of a large European prospective cohort. Results: A metabolic pattern associated with HCC risk comprised of perturbations in fatty acid oxidation and amino acid, lipid, and carbohydrate metabolism was observed. Sixteen metabolites of either endogenous or exogenous origin were found to be significantly associated with HCC risk. The influence of hepatitis infection and potential liver damage was assessed, and further analyses were made to distinguish patterns of early or later diagnosis. Conclusion: Our results show clear metabolic alterations from early stages of HCC development with application for better etiologic understanding, prevention, and early detection of this increasingly common cancer.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Circulating insulin-like growth factor I in relation to melanoma risk in the European Prospective Investigation into Cancer and Nutrition

  • Bradbury, Kathryn E.
  • Appleby, Paul N.
  • Tipper, Sarah J.
  • Travis, Ruth C.
  • Allen, Naomi E.
  • Kvaskoff, Marina
  • Overvad, Kim
  • Tjønneland, Anne
  • Halkjær, Jytte
  • Cervenka, Iris
  • Mahamat-Saleh, Yahya
  • Bonnet, Fabrice
  • Kaaks, Rudolf
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Stratigos, Alexander J.
  • Palli, Domenico
  • Grioni, Sara
  • Matullo, Giuseppe
  • Panico, Salvatore
  • Tumino, Rosario
  • Peeters, Petra H. M.
  • Bueno de Mesquita, H. Bas
  • Ghiasvand, Reza
  • Veierød, Marit B.
  • Weiderpass, Elisabete
  • Bonet Bonet, Catalina
  • Molina, Elena
  • Huerta Castaño, José María
  • Larrañaga, Nerea
  • Barricarte, Aurelio
  • Merino, Susana
  • Isaksson, Karolin
  • Stocks, Tanja
  • Ljuslinder, Ingrid
  • Hemmingsson, Oskar
  • Wareham, Nick
  • Khaw, Kay‐Tee
  • Gunter, Marc J.
  • Rinaldi, Sabina
  • Tsilidis, Konstantinos K.
  • Aune, Dagfinn
  • Riboli, Elio
  • Key, Timothy J.
Insulin-like growth factor-I (IGF-I) regulates cell proliferation and apoptosis, and is thought to play a role in tumour development. Previous prospective studies have shown that higher circulating concentrations of IGF-I are associated with a higher risk of cancers at specific sites, including breast and prostate. No prospective study has examined the association between circulating IGF-I concentrations and melanoma risk. A nested case-control study of 1,221 melanoma cases and 1,221 controls was performed in the European Prospective Investigation into Cancer and Nutrition cohort, a prospective cohort of 520,000 participants recruited from 10 European countries. Conditional logistic regression was used to estimate odds ratios (ORs) for incident melanoma in relation to circulating IGF-I concentrations, measured by immunoassay. Analyses were conditioned on the matching factors and further adjusted for age at blood collection, education, height, BMI, smoking status, alcohol intake, marital status, physical activity and in women only, use of menopausal hormone therapy. There was no significant association between circulating IGF-I concentration and melanoma risk (OR for highest vs lowest fifth = 0.93 [95% confidence interval [CI]: 0.71 to 1.22]). There was no significant heterogeneity in the association between IGF-I concentrations and melanoma risk when subdivided by gender, age at blood collection, BMI, height, age at diagnosis, time between blood collection and diagnosis, or by anatomical site or histological subtype of the tumour (Pheterogeneity≥0.078). We found no evidence for an association between circulating concentrations of IGF-I measured in adulthood and the risk of melanoma.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort

  • Idahl, Annika
  • Cornet, Charlotte Le
  • González Maldonado, Sandra
  • Waterboer, Tim
  • Bender, Noemi
  • Tjønneland, Anne
  • Hansen, Louise
  • Boutron-Ruault, Marie-Christine
  • Fournier, Agnès
  • Kvaskoff, Marina
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Valanou, Elisavet
  • Peppa, Eleni
  • Palli, Domenico
  • Agnoli, Claudia
  • Mattiello, Amalia
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Onland-Moret, N. Charlotte
  • Gram, Inger T.
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Duell, Eric J.
  • Sánchez, María José
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Gil, Leire
  • Brändstedt, Jenny
  • Riesbeck, Kristian
  • Lundin, Eva
  • Khaw, Kay‐Tee
  • Pérez Cornago, Aurora
  • Gunter, Marc J.
  • Dossus, Laure
  • Kaaks, Rudolf
  • Fortner, Renée T.
A substantial proportion of epithelial ovarian cancer (EOC) arises in the fallopian tube and other epithelia of the upper genital tract; these epithelia may incur damage and neoplastic transformation after sexually transmitted infections (STI) and pelvic inflammatory disease. We investigated the hypothesis that past STI infection, particularly Chlamydia trachomatis, is associated with higher EOC risk in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort including 791 cases and 1669 matched controls. Serum antibodies against C. trachomatis, Mycoplasma genitalium, herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) 16, 18 and 45 were assessed using multiplex fluorescent bead-based serology. Conditional logistic regression was used to estimate relative risks (RR) and 95% confidence intervals (CI) comparing women with positive vs. negative serology. A total of 40% of the study population was seropositive to at least one STI. Positive serology to C. trachomatis Pgp3 antibodies was not associated with EOC risk overall, but with higher risk of the mucinous histotype (RR = 2.30 [95% CI = 1.22-4.32]). Positive serology for chlamydia heat shock protein 60 (cHSP60-1) was associated with higher risk of EOC overall (1.36 [1.13-1.64]) and with the serous subtype (1.44 [1.12-1.85]). None of the other evaluated STIs were associated with EOC risk overall; however, HSV-2 was associated with higher risk of endometrioid EOC (2.35 [1.24-4.43]). The findings of our study suggest a potential role of C. trachomatis in the carcinogenesis of serous and mucinous EOC, while HSV-2 might promote the development of endometrioid disease.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort

  • Molina Montes, Esther
  • Sánchez, María José
  • Buckland, Genevieve
  • Bueno de Mesquita, H. Bas
  • Weiderpass, Elisabete
  • Amiano, Pilar
  • Wark, Petra A.
  • Kühn, Tilman
  • Katzke, Verena
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Quirós, José Ramón
  • Affret, Aurélie
  • His, Mathilde
  • Boutron-Ruault, Marie-Christine
  • Peeters, Petra H. M.
  • Ye, Weimin
  • Sund, Malin
  • Boeing, Heiner
  • Iqbal, Khalid
  • Ohlsson, Bodil
  • Sonestedt, Emily
  • Tjønneland, Anne
  • Petersen, Kristina Elin Nielsen
  • Travis, Ruth C.
  • Skeie, Guri
  • Agnoli, Claudia
  • Panico, Salvatore
  • Palli, Domenico
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Freisling, Heinz
  • Huybrechts, Inge
  • Overvad, Kim
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Vasilopoulou, Effie
  • Wareham, Nicholas J.
  • Khaw, Kay-Tee
  • Cross, Amanda J.
  • Ward, Heather A.
  • Riboli, Elio
  • Duell, Eric J.
Background: The Mediterranean diet (MD) has been proposed as a means for cancer prevention, but little evidence has been accrued regarding its potential to prevent pancreatic cancer. We investigated the association between the adherence to the MD and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Methods: Over half a million participants from 10 European countries were followed up for over 11 years, after which 865 newly diagnosed exocrine pancreatic cancer cases were identified. Adherence to the MD was estimated through an adapted score without the alcohol component (arMED) to discount alcohol-related harmful effects. Cox proportional hazards regression models, stratified by age, sex and centre, and adjusted for energy intake, body mass index, smoking status, alcohol intake and diabetes status at recruitment, were used to estimate hazard ratios (HRs) associated with pancreatic cancer and their corresponding 95% confidence intervals (CIs). Results: Adherence to the arMED score was not associated with risk of pancreatic cancer (HR high vs low adherence = 0.99; 95% CI: 0.77-1.26, and HR per increments of two units in adherence to arMED = 1.00; 95% CI: 0.94-1.06). There was no convincing evidence for heterogeneity by smoking status, body mass index, diabetes or European region. There was also no evidence of significant associations in analyses involving microscopically confirmed cases, plausible reporters of energy intake or other definitions of the MD pattern. Conclusions: A high adherence to the MD is not associated with pancreatic cancer risk in the EPIC study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

  • Fortner, Renée T.
  • Vitonis, Allison F.
  • Schock, Helena
  • Hüsing, Anika
  • Johnson, Theron
  • Fichorova, Raina N.
  • Fashemi, Titilayo
  • Yamamoto, Hidemi S.
  • Tjønneland, Anne
  • Hansen, Louise
  • Overvad, Kim
  • Boutron-Ruault, Marie-Christine
  • Kvaskoff, Marina
  • Severi, Gianluca
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Benetou, Vassiliki
  • Vecchia, Carlo La
  • Palli, Domenico
  • Sieri, Sabina
  • Tumino, Rosario
  • Matullo, Giuseppe
  • Mattiello, Amalia
  • Onland-Moret, N. Charlotte
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Gram, Inger T.
  • Jareid, Mie
  • Quirós, José Ramón
  • Duell, Eric J.
  • Sánchez, María José
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Larrañaga, Nerea
  • Nodin, Björn
  • Brandstedt, Jenny
  • Idahl, Annika
  • Khaw, Kay-Tee
  • Allen, Naomi E.
  • Gunter, Marc J.
  • Johansson, Mattias
  • Dossus, Laure
  • Merritt, Melissa A.
  • Riboli, Elio
  • Cramer, Daniel W.
  • Kaaks, Rudolf
  • Terry, Kathryn L.
Background: Ovarian cancer early detection markers CA125, CA15.3, HE4, and CA72.4 vary between healthy women, limiting their utility for screening. Methods: We evaluated cross-sectional relationships between lifestyle and reproductive factors and these markers among controls (n = 1910) from a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Improvements in discrimination of prediction models adjusting for correlates of the markers were evaluated among postmenopausal women in the nested case-control study (n = 590 cases). Generalized linear models were used to calculate geometric means of CA125, CA15.3, and HE4. CA72.4 above vs. below limit of detection was evaluated using logistic regression. Early detection prediction was modeled using conditional logistic regression. Results: CA125 concentrations were lower, and CA15.3 higher, in post-vs. premenopausal women (p <= 0.02). Among postmenopausal women, CA125 was higher among women with higher parity and older age at menopause (p(trend) <= 0. 02), but lower among women reporting oophorectomy, hysterectomy, ever use of estrogen-only hormone therapy, or current smoking (p < 0.01). CA15.3 concentrations were higher among heavier women and in former smokers (p <= 0.03). HE4 was higher with older age at blood collection and in current smokers, and inversely associated with OC use duration, parity, and older age at menopause (<= 0.02). No associations were observed with CA72.4. Adjusting for correlates of the markers in prediction models did not improve the discrimination. Conclusions: This study provides insights into sources of variation in ovarian cancer early detection markers in healthy women and informs about the utility of individualizing marker cutpoints based on epidemiologic factors.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Development and validation of circulating CA125 prediction models in postmenopausal women

  • Sasamoto, Naoko
  • Babic, Ana
  • Rosner, Bernard A.
  • Fortner, Renée T.
  • Vitonis, Allison F.
  • Yamamoto, Hidemi
  • Fichorova, Raina N.
  • Titus, Linda J.
  • Tjønneland, Anne
  • Hansen, Louise
  • Kvaskoff, Marina
  • Fournier, Agnès
  • Mancini, Francesca Romana
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Peppa, Eleni
  • Karakatsani, Anna
  • Palli, Domenico
  • Grioni, Sara
  • Mattiello, Amalia
  • Tumino, Rosario
  • Fiano, Valentina
  • Onland-Moret, N. Charlotte
  • Weiderpass, Elisabete
  • Gram, Inger T.
  • Quirós, José Ramón
  • Luján Barroso, Leila
  • Sánchez, María José
  • Colorado-Yohar, Sandra
  • Barricarte, Aurelio
  • Amiano, Pilar
  • Idahl, Annika
  • Lundin, Eva
  • Sartor, Hanna
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Muller, David C.
  • Riboli, Elio
  • Gunter, Marc J.
  • Dossus, Laure
  • Trabert, Britton
  • Wentzensen, Nicolas
  • Kaaks, Rudolf
  • Cramer, Daniel W.
  • Tworoger, Shelley S.
  • Terry, Kathryn L.
Background Cancer Antigen 125 (CA125) is currently the best available ovarian cancer screening biomarker. However, CA125 has been limited by low sensitivity and specificity in part due to normal variation between individuals. Personal characteristics that influence CA125 could be used to improve its performance as screening biomarker. Methods We developed and validated linear and dichotomous (>= 35 U/mL) circulating CA125 prediction models in postmenopausal women without ovarian cancer who participated in one of five large population-based studies: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, n = 26,981), European Prospective Investigation into Cancer and Nutrition (EPIC, n = 861), the Nurses' Health Studies (NHS/NHSII, n = 81), and the New England Case Control Study (NEC, n = 923). The prediction models were developed using stepwise regression in PLCO and validated in EPIC, NHS/NHSII and NEC. Result The linear CA125 prediction model, which included age, race, body mass index (BMI), smoking status and duration, parity, hysterectomy, age at menopause, and duration of hormone therapy (HT), explained 5% of the total variance of CA125. The correlation between measured and predicted CA125 was comparable in PLCO testing dataset (r = 0.18) and external validation datasets (r = 0.14). The dichotomous CA125 prediction model included age, race, BMI, smoking status and duration, hysterectomy, time since menopause, and duration of HT with AUC of 0.64 in PLCO and 0.80 in validation dataset. Conclusions The linear prediction model explained a small portion of the total variability of CA125, suggesting the need to identify novel predictors of CA125. The dichotomous prediction model showed moderate discriminatory performance which validated well in independent dataset. Our dichotomous model could be valuable in identifying healthy women who may have elevated CA125 levels, which may contribute to reducing false positive tests using CA125 as screening biomarker.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A Body Shape Index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort

  • Christakoudi, Sofia
  • Tsilidis, Konstantinos K.
  • Muller, David C.
  • Freisling, Heinz
  • Weiderpass, Elisabete
  • Overvad, Kim
  • Soderberg, Stefan
  • Haggstrom, Christel
  • Pischon, Tobias
  • Dahm, Christina C.
  • Zhang, Jie
  • Tjønneland, Anne
  • Halkjær, Jytte
  • MacDonald, Conor
  • Boutron-Ruault, Marie-Christine
  • Mancini, Francesca Romana
  • Kühn, Tilman
  • Kaaks, Rudolf
  • Schulze, Matthias B.
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Peppa, Eleni
  • Masala, Giovanna
  • Pala, Valeria
  • Panico, Salvatore
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Quirós, José Ramón
  • Agudo, Antonio
  • Sánchez, María José
  • Cirera, Lluís
  • Barricarte, Aurelio
  • Amiano, Pilar
  • Memarian, Ensieh
  • Sonestedt, Emily
  • Bueno de Mesquita, H. Bas
  • May, Anne M.
  • Khaw, Kay‑Tee
  • Wareham, Nicholas J.
  • Tong, Tammy Y. N.
  • Huybrechts, Inge
  • Noh, Hwayoung
  • Aglago, Elom K.
  • Ellingjord-Dale, Merete
  • Ward, Heather A.
  • Aune, Dagfinn
  • Riboli, Elio
Abdominal and general adiposity are independently associated with mortality, but there is no consensus on how best to assess abdominal adiposity. We compared the ability of alternative waist indices to complement body mass index (BMI) when assessing all-cause mortality. We used data from 352,985 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) and Cox proportional hazards models adjusted for other risk factors. During a mean follow-up of 16.1 years, 38,178 participants died. Combining in one model BMI and a strongly correlated waist index altered the association patterns with mortality, to a predominantly negative association for BMI and a stronger positive association for the waist index, while combining BMI with the uncorrelated A Body Shape Index (ABSI) preserved the association patterns. Sex-specific cohort-wide quartiles of waist indices correlated with BMI could not separate high-risk from low-risk individuals within underweight (BMI<18.5 kg/m(2)) or obese (BMI<greater than or equal to>30 kg/m(2)) categories, while the highest quartile of ABSI separated 18-39% of the individuals within each BMI category, which had 22-55% higher risk of death. In conclusion, only a waist index independent of BMI by design, such as ABSI, complements BMI and enables efficient risk stratification, which could facilitate personalisation of screening, treatment and monitoring.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study

  • Ritte, Rebecca
  • Tikk, Kaja
  • Lukanova, Annekatrin
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Dossus, Laure
  • Fournier, Agnès
  • Clavel-Chapelon, Françoise
  • Grote, Verena A.
  • Boeing, Heiner
  • Aleksandrova, Krasimira
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Berrino, Franco
  • Mattiello, Amalia
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Quirós, José Ramón
  • Buckland, Genevieve
  • Molina Montes, Esther
  • Chirlaque, María Dolores
  • Ardanaz, Eva
  • Amiano, Pilar
  • Bueno de Mesquita, H. Bas
  • van Gils, Carla H.
  • Peeters, Petra H. M.
  • Wareham, Nicholas J.
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Travis, Ruth C.
  • Weiderpass, Elisabete
  • Dumeaux, Vanessa
  • Lund, Eiliv
  • Sund, Malin
  • Andersson, Anne
  • Romieu, Isabelle
  • Rinaldi, Sabina
  • Vineis, Paolo
  • Merritt, Melissa A.
  • Riboli, Elio
  • Kaaks, Rudolf
Background: The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain. Methods: Within the EPIC cohort, Cox proportional hazards models were used to describe the relationships of reproductive factors (menarcheal age, time between menarche and first pregnancy, parity, number of children, age at first and last pregnancies, time since last full-term childbirth, breastfeeding, age at menopause, ever having an abortion and use of oral contraceptives [OC]) with risk of ER-PR-(n = 998) and ER+PR+ (n = 3,567) breast tumors. Results: A later first full-term childbirth was associated with increased risk of ER+PR+ tumors but not with risk of ER-PR-tumors (= 35 vs. = 19 years HR: 1.47 [95% CI 1.15-1.88] p(trend) < 0.001 for ER+PR+ tumors; = 35 vs. = 19 years HR: 0.93 [95% CI 0.53-1.65] p(trend) = 0.96 for ER-PR-tumors; P-het = 0.03). The risk associations of menarcheal age, and time period between menarche and first full-term childbirth with ER-PR-tumors were in the similar direction with risk of ER+PR+ tumors (p(het) = 0.50), although weaker in magnitude and statistically only borderline significant. Other parity related factors such as ever a full-term birth, number of births, age-and time since last birth were associated only with ER+PR+ malignancies, however no statistical heterogeneity between breast cancer subtypes was observed. Breastfeeding and OC use were generally not associated with breast cancer subtype risk. Conclusion: Our study provides possible evidence that age at menarche, and time between menarche and first full-term childbirth may be associated with the etiology of both HR-negative and HR-positive malignancies, although the associations with HR-negative breast cancer were only borderline significant.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study

  • Tikk, Kaja
  • Sookthai, Disorn
  • Fortner, Renée T.
  • Johnson, Theron
  • Rinaldi, Sabina
  • Romieu, Isabelle
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Clavel-Chapelon, Françoise
  • Baglietto, Laura
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Masala, Giovanna
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Mattiello, Amalia
  • Agudo, Antonio
  • Menéndez, Virginia
  • Sánchez, María José
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Bueno de Mesquita, H. Bas
  • Monninkhof, Evelyn M.
  • Onland-Moret, N. Charlotte
  • Andresson, Anne
  • Sund, Malin
  • Weiderpass, Elisabete
  • Khaw, Kay-Tee
  • Key, Timothy J.
  • Travis, Ruth C.
  • Merritt, Melissa A.
  • Riboli, Elio
  • Dossus, Laure
  • Kaaks, Rudolf
Introduction: The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention. Methods: We analysed the relationship between pre-diagnostic prolactin levels and the risk of in situ breast cancer overall, and by menopausal status and use of postmenopausal hormone therapy (HT) at blood donation. Conditional logistic regression was used to assess this association in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, including 307 in situ breast cancer cases and their matched control subjects. Results: We found a significant positive association between higher circulating prolactin levels and risk of in situ breast cancer among all women [pre-and postmenopausal combined, ORlog2 = 1.35 (95% CI 1.04-1.76), P-trend = 0.03]. No statistically significant heterogeneity was found between prolactin levels and in situ cancer risk by menopausal status (P-het = 0.98) or baseline HT use (P-het = 0.20), although the observed association was more pronounced among postmenopausal women using HT compared to non-users (P-trend = 0.06 vs P-trend = 0.35). In subgroup analyses, the observed positive association was strongest in women diagnosed with in situ breast tumors <4 years compared to >= 4 years after blood donation (P-trend = 0.01 vs P-trend = 0.63; P-het = 0.04) and among nulliparous women compared to parous women (P-trend = 0.03 vs P-trend = 0.15; P-het = 0.07). Conclusions: Our data extends prior research linking prolactin and invasive breast cancer to the outcome of in situ breast tumours and shows that higher circulating prolactin is associated with increased risk of in situ breast cancer. The relationship between circulating prolactin and invasive breast cancer has been investigated previously, but the association between prolactin levels and in situ breast cancer risk has received less attention.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Prospective analysis of circulating metabolites and breast cancer in EPIC

  • His, Mathilde
  • Viallon, Vivian
  • Dossus, Laure
  • Gicquiau, Audrey
  • Achaintre, David
  • Scalbert, Augustin
  • Ferrari, Pietro
  • Romieu, Isabelle
  • Onland-Moret, N. Charlotte
  • Weiderpass, Elisabete
  • Dahm, Christina C.
  • Overvad, Kim
  • Olsen, Anja
  • Tjønneland, Anne
  • Fournier, Agnès
  • Rothwell, Joseph A.
  • Severi, Gianluca
  • Kühn, Tilman
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Karakatsani, Anna
  • Martimianaki, Georgia
  • Masala, Giovanna
  • Sieri, Sabina
  • Tumino, Rosario
  • Vineis, Paolo
  • Panico, Salvatore
  • van Gils, Carla H.
  • Nøst, Therese Haugdahl
  • Sandanger, Torkjel M.
  • Skeie, Guri
  • Quirós, José Ramón
  • Agudo, Antonio
  • Sánchez, María José
  • Amiano, Pilar
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Schmidt, Julie A.
  • Travis, Ruth C.
  • Riboli, Elio
  • Tsilidis, Konstantinos K.
  • Christakoudi, Sofia
  • Gunter, Marc J.
  • Rinaldi, Sabina
Background: Metabolomics is a promising molecular tool to identify novel etiologic pathways leading to cancer. Using a targeted approach, we prospectively investigated the associations between metabolite concentrations in plasma and breast cancer risk. Methods: A nested case-control study was established within the European Prospective Investigation into Cancer cohort, which included 1624 first primary incident invasive breast cancer cases (with known estrogen and progesterone receptor and HER2 status) and 1624 matched controls. Metabolites (n = 127, acylcarnitines, amino acids, biogenic amines, glycerophospholipids, hexose, sphingolipids) were measured by mass spectrometry in pre-diagnostic plasma samples and tested for associations with breast cancer incidence using multivariable conditional logistic regression. Results: Among women not using hormones at baseline (n = 2248), and after control for multiple tests, concentrations of arginine (odds ratio [OR] per SD = 0.79, 95% confidence interval [CI] = 0.70-0.90), asparagine (OR = 0.83 (0.74-0.92)), and phosphatidylcholines (PCs) ae C36:3 (OR = 0.83 (0.76-0.90)), aa C36:3 (OR = 0.84 (0.77-0.93)), ae C34:2 (OR = 0.85 (0.78-0.94)), ae C36:2 (OR = 0.85 (0.78-0.88)), and ae C38:2 (OR = 0.84 (0.76-0.93)) were inversely associated with breast cancer risk, while the acylcarnitine C2 (OR = 1.23 (1.11-1.35)) was positively associated with disease risk. In the overall population, C2 (OR = 1.15 (1.06-1.24)) and PC ae C36:3 (OR = 0.88 (0.82-0.95)) were associated with risk of breast cancer, and these relationships did not differ by breast cancer subtype, age at diagnosis, fasting status, menopausal status, or adiposity. Conclusions: These findings point to potentially novel pathways and biomarkers of breast cancer development. Results warrant replication in other epidemiological studies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Plasma polyphenols associated with lower high-sensitivity C-reactive protein concentrations: a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  • Harms, Laura M.
  • Scalbert, Augustin
  • Zamora-Ros, Raul
  • Rinaldi, Sabina
  • Jenab, Mazda
  • Murphy, Neil
  • Achaintre, David
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Mancini, Francesca Romana
  • Mahamat-Saleh, Yahya
  • Boutron-Ruault, Marie-Christine
  • Kühn, Tilman
  • Katzke, Verena
  • Trichopoulou, Antonia
  • Martimianaki, Georgia
  • Karakatsani, Anna
  • Palli, Domenico
  • Panico, Salvatore
  • Sieri, Sabina
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Bueno de Mesquita, H. Bas
  • Vermeulen, Roel C. H.
  • Weiderpass, Elisabete
  • Haugdahl Nøst, Therese
  • Lasheras, Cristina
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Barricarte, Aurelio
  • Dorronsoro, Miren
  • Hultdin, Johan
  • Schmidt, Julie A.
  • Gunter, Marc J.
  • Riboli, Elio
  • Aleksandrova, Krasimira
Experimental studies have reported on the anti-inflammatory properties of polyphenols. However, results from epidemiological investigations have been inconsistent and especially studies using biomarkers for assessment of polyphenol intake have been scant. We aimed to characterise the association between plasma concentrations of thirty-five polyphenol compounds and low-grade systemic inflammation state as measured by high-sensitivity C-reactive protein (hsCRP). A cross-sectional data analysis was performed based on 315 participants in the European Prospective Investigation into Cancer and Nutrition cohort with available measurements of plasma polyphenols and hsCRP. In logistic regression analysis, the OR and 95 % CI of elevated serum hsCRP (>3 mg/l) were calculated within quartiles and per standard deviation higher level of plasma polyphenol concentrations. In a multivariable-adjusted model, the sum of plasma concentrations of all polyphenols measured (per standard deviation) was associated with 29 (95 % CI 50, 1) % lower odds of elevated hsCRP. In the class of flavonoids, daidzein was inversely associated with elevated hsCRP (OR 0 center dot 66, 95 % CI 0 center dot 46, 0 center dot 96). Among phenolic acids, statistically significant associations were observed for 3,5-dihydroxyphenylpropionic acid (OR 0 center dot 58, 95 % CI 0 center dot 39, 0 center dot 86), 3,4-dihydroxyphenylpropionic acid (OR 0 center dot 63, 95 % CI 0 center dot 46, 0 center dot 87), ferulic acid (OR 0 center dot 65, 95 % CI 0 center dot 44, 0 center dot 96) and caffeic acid (OR 0 center dot 69, 95 % CI 0 center dot 51, 0 center dot 93). The odds of elevated hsCRP were significantly reduced for hydroxytyrosol (OR 0 center dot 67, 95 % CI 0 center dot 48, 0 center dot 93). The present study showed that polyphenol biomarkers are associated with lower odds of elevated hsCRP. Whether diet rich in bioactive polyphenol compounds could be an effective strategy to prevent or modulate deleterious health effects of inflammation should be addressed by further well-powered longitudinal studies.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations

  • van Duijnhoven, Franzel J. B.
  • Jenab, Mazda
  • Hveem, Kristian
  • Siersema, Peter D.
  • Fedirko, Veronika
  • Duell, Eric J.
  • Kampman, Ellen
  • Halfweeg, Anouk
  • van Kranen, Henk J.
  • van den Ouweland, Jody M. W.
  • Weiderpass, Elisabete
  • Murphy, Neil
  • Langhammer, Arnulf
  • Ness-Jensen, Eivind
  • Olsen, Anja
  • Tjønneland, Anne
  • Overvad, Kim
  • Cadeau, Claire
  • Kvaskoff, Marina
  • Boutron-Ruault, Marie-Christine
  • Katzke, Verena
  • Kühn, Tilman
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Kotanidou, Anastasia
  • Kritikou, Maria
  • Palli, Domenico
  • Agnoli, Claudia
  • Tumino, Rosario
  • Panico, Salvatore
  • Matullo, Giuseppe
  • Peeters, Petra H. M.
  • Brustad, Magritt
  • Olsen, Karina Standahl
  • Lasheras, Cristina
  • Obón Santacana, Mireia
  • Sánchez, María José
  • Dorronsoro, Miren
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Manjer, Jonas
  • Almquist, Martin
  • Renström, Frida
  • Ye, Weimin
  • Wareham, Nick
  • Khaw, Kay-Tee
  • Bradbury, Kathryn E.
  • Freisling, Heinz
  • Aune, Dagfinn
  • Norat, Teresa
  • Riboli, Elio
  • Bueno de Mesquita, H. Bas
Evidence from in vivo, in vitro and ecological studies are suggestive of a protective effect of vitamin D against pancreatic cancer (PC). However, this has not been confirmed by analytical epidemiological studies. We aimed to examine the association between pre-diagnostic circulating vitamin D concentrations and PC incidence in European populations. We conducted a pooled nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) and the Nord-Trøndelag Health Study's second survey (HUNT2) cohorts. In total, 738 primary incident PC cases (EPIC n = 626; HUNT2 n = 112; median follow-up = 6.9 years) were matched to 738 controls. Vitamin D [25(OH)D2 and 25(OH)D3 combined] concentrations were determined using isotope-dilution liquid chromatography-tandem mass spectrometry. Conditional logistic regression models with adjustments for body mass index and smoking habits were used to estimate incidence rate ratios (IRRs) and 95% confidence intervals (95%CI). Compared with a reference category of >50 to 75 nmol/L vitamin D, the IRRs (95% CIs) were 0.71 (0.42-1.20); 0.94 (0.72-1.22); 1.12 (0.82-1.53) and 1.26 (0.79-2.01) for clinically pre-defined categories of ≤25; >25 to 50; >75 to 100; and >100 nmol/L vitamin D, respectively (p for trend = 0.09). Corresponding analyses by quintiles of season-standardized vitamin D concentrations also did not reveal associations with PC risk (p for trend = 0.23). Although these findings among participants from the largest combination of European cohort studies to date show increasing effect estimates of PC risk with increasing pre-diagnostic concentrations of vitamin D, they are not statistically significant.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study

  • Merritt, Melissa A.
  • Riboli, Elio
  • Murphy, Neil
  • Kadi, Mai
  • Tjønneland, Anne
  • Olsen, Anja
  • Overvad, Kim
  • Dossus, Laure
  • Dartois, Laureen
  • Clavel-Chapelon, Françoise
  • Fortner, Renée T.
  • Katzke, Verena
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Sieri, Sabina
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Lund, Eiliv
  • Nakamura, Aurelie
  • Weiderpass, Elisabete
  • Quirós, José Ramón
  • Agudo, Antonio
  • Molina Montes, Esther
  • Larrañaga, Nerea
  • Dorronsoro, Miren
  • Cirera, Lluís
  • Barricarte, Aurelio
  • Olsson, Åsa
  • Butt, Salma Tunå
  • Idahl, Annika
  • Lundin, Eva
  • Wareham, Nicholas J.
  • Key, Timothy J.
  • Brennan, Paul
  • Ferrari, Pietro
  • Wark, Petra A.
  • Norat, Teresa
  • Cross, Amanda J.
  • Gunter, Marc J.
Background: Reproductive events are associated with important physiologic changes, yet little is known about how reproductive factors influence long-term health in women. Our objective was to assess the relation of reproductive characteristics with all-cause and cause-specific mortality risk. Methods: The analysis was performed within the European Investigation into Cancer and Nutrition prospective cohort study, which enrolled > 500,000 women and men from 1992 to 2000, who were residing in a given town/geographic area in 10 European countries. The current analysis included 322,972 eligible women aged 25-70 years with 99 % complete follow-up for vital status. We assessed reproductive characteristics reported at the study baseline including parity, age at the first birth, breastfeeding, infertility, oral contraceptive use, age at menarche and menopause, total ovulatory years, and history of oophorectomy/hysterectomy. Hazard ratios (HRs) and 95 % confidence intervals (CIs) for mortality were determined using Cox proportional hazards regression models adjusted for menopausal status, body mass index, physical activity, education level, and smoking status/intensity and duration. Results: During a mean follow-up of 12.9 years, 14,383 deaths occurred. The HR (95 % CI) for risk of all-cause mortality was lower in parous versus nulliparous women (0.80; 0.76-0.84), in women who had ever versus never breastfed (0.92; 0.87-0.97), in ever versus never users of oral contraceptives (among non-smokers; 0.90; 0.86-0.95), and in women reporting a later age at menarche (>= 15 years versus < 12; 0.90; 0.85-0.96; P for trend = 0.038). Conclusions: Childbirth, breastfeeding, oral contraceptive use, and a later age at menarche were associated with better health outcomes. These findings may contribute to the development of improved strategies to promote better long-term health in women.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

  • Sarink, Danja
  • Schock, Helena
  • Johnson, Theron
  • Chang-Claude, Jenny
  • Overvad, Kim
  • Olsen, Anja
  • Tjønneland, Anne
  • Arveux, Patrick
  • Fournier, Agnès
  • Kvaskoff, Marina
  • Boeing, Heiner
  • Karakatsani, Anna
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Masala, Giovanni
  • Agnoli, Claudia
  • Panico, Salvatore
  • Tumino, Rosario
  • Sacerdote, Carlotta
  • van Gils, Carla H.
  • Peeters, Petra H. M.
  • Weiderpass, Elisabete
  • Agudo, Antonio
  • Rodríguez Barranco, Miguel
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Gil, Leire
  • Kaw, Kay Tee
  • Schmidt, Julie A.
  • Dossus, Laure
  • His, Mathilde
  • Aune, Dagfinn
  • Riboli, Elio
  • Kaaks, Rudolf
  • Fortner, Renée T.
Background: Receptor activator of nuclear factor kappa-B (RANK)-signaling is involved in tumor growth and spread in experimental models. Binding of RANK ligand (RANKL) to RANK activates signaling, which is inhibited by osteoprotegerin (OPG). We have previously shown that circulating soluble RANKL (sRANKL) and OPG are associated with breast cancer risk. Here we extend these findings to provide the first data on pre-diagnosis concentrations of sRANKL and OPG and risk of breast cancer-specific and overall mortality after a breast cancer diagnosis. Methods: Two thousand six pre- and postmenopausal women with incident invasive breast cancer (1620 (81%) with ER+ disease) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort were followed-up for mortality. Pre-diagnosis concentrations of sRANKL and OPG were quantified in baseline serum samples using an enzyme-linked immunosorbent assay and electrochemiluminescent assay, respectively. Hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer-specific and overall mortality were calculated using Cox proportional hazards regression models. Results: Especially in women with ER+ disease, higher circulating OPG concentrations were associated with higher risk of breast cancer-specific (quintile 5 vs 1 HR 1.77 [CI 1.03, 3.04]; ptrend 0.10) and overall mortality (q5 vs 1 HR 1.39 [CI 0.94, 2.05]; ptrend 0.02). sRANKL and the sRANKL/OPG ratio were not associated with mortality following a breast cancer diagnosis. Conclusions: High pre-diagnosis endogenous concentrations of OPG, the decoy receptor for RANKL, were associated with increased risk of death after a breast cancer diagnosis, especially in those with ER+ disease. These results need to be confirmed in well-characterized patient cohorts.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

  • Castellví Bel, Sergi
  • Moreno Aguado, Víctor
Background: Higher adiposity increases the risk of colorectal cancer (CRC), but whether this relationship varies by anatomical sub-site or by sex is unclear. Further, the metabolic alterations mediating the effects of adiposity on CRC are not fully understood. Methods: We examined sex- and site-specific associations of adiposity with CRC risk and whether adiposity-associated metabolites explain the associations of adiposity with CRC. Genetic variants from genome-wide association studies of body mass index (BMI) and waist-to-hip ratio (WHR, unadjusted for BMI; N = 806,810), and 123 metabolites from targeted nuclear magnetic resonance metabolomics (N = 24,925), were used as instruments. Sex-combined and sex-specific Mendelian randomization (MR) was conducted for BMI and WHR with CRC risk (58,221 cases and 67,694 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry). Sex-combined MR was conducted for BMI and WHR with metabolites, for metabolites with CRC, and for BMI and WHR with CRC adjusted for metabolite classes in multivariable models. Results: In sex-specific MR analyses, higher BMI (per 4.2 kg/m2) was associated with 1.23 (95% confidence interval (CI) = 1.08, 1.38) times higher CRC odds among men (inverse-variance-weighted (IVW) model); among women, higher BMI (per 5.2 kg/m2) was associated with 1.09 (95% CI = 0.97, 1.22) times higher CRC odds. WHR (per 0.07 higher) was more strongly associated with CRC risk among women (IVW OR = 1.25, 95% CI = 1.08, 1.43) than men (IVW OR = 1.05, 95% CI = 0.81, 1.36). BMI or WHR was associated with 104/123 metabolites at false discovery rate-corrected P ≤ 0.05; several metabolites were associated with CRC, but not in directions that were consistent with the mediation of positive adiposity-CRC relations. In multivariable MR analyses, associations of BMI and WHR with CRC were not attenuated following adjustment for representative metabolite classes, e.g., the univariable IVW OR for BMI with CRC was 1.12 (95% CI = 1.00, 1.26), and this became 1.11 (95% CI = 0.99, 1.26) when adjusting for cholesterol in low-density lipoprotein particles. Conclusions: Our results suggest that higher BMI more greatly raises CRC risk among men, whereas higher WHR more greatly raises CRC risk among women. Adiposity was associated with numerous metabolic alterations, but none of these explained associations between adiposity and CRC. More detailed metabolomic measures are likely needed to clarify the mechanistic pathways.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study

  • Aleksandrova, Krasimira
  • Pischon, Tobias
  • Jenab, Mazda
  • Bueno de Mesquita, H. Bas
  • Fedirko, Veronika
  • Norat, Teresa
  • Romaguera, Dora
  • Knüppel, Sven
  • Boutron-Ruault, Marie-Christine
  • Dossus, Laure
  • Dartois, Laureen
  • Kaaks, Rudolf
  • Li, Kuanrong
  • Tjønneland, Anne
  • Overvad, Kim
  • Quirós, José Ramón
  • Buckland, Genevieve
  • Sánchez, María José
  • Dorronsoro, Miren
  • Chirlaque, María Dolores
  • Barricarte, Aurelio
  • Khaw, Kay-Tee
  • Wareham, Nicholas J.
  • Bradbury, Kathryn E.
  • Trichopoulou, Antonia
  • Lagiou, Pagona
  • Trichopoulos, Dimitrios
  • Palli, Domenico
  • Krogh, Vittorio
  • Tumino, Rosario
  • Naccarati, Alessio
  • Panico, Salvatore
  • Siersema, Peter D.
  • Peeters, Petra H. M.
  • Ljuslinder, Ingrid
  • Johansson, Ingegerd
  • Ericson, Ulrika
  • Ohlsson, Bodil
  • Weiderpass, Elisabete
  • Skeie, Guri
  • Benjaminsen Borch, Kristin
  • Rinaldi, Sabina
  • Romieu, Isabelle
  • Kong, Joyce
  • Gunter, Marc J.
  • Ward, Heather A.
  • Riboli, Elio
  • Boeing, Heiner
Background: Excess body weight, physical activity, smoking, alcohol consumption and certain dietary factors are individually related to colorectal cancer (CRC) risk; however, little is known about their joint effects. The aim of this study was to develop a healthy lifestyle index (HLI) composed of five potentially modifiable lifestyle factors healthy weight, physical activity, non-smoking, limited alcohol consumption and a healthy diet, and to explore the association of this index with CRC incidence using data collected within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Methods: In the EPIC cohort, a total of 347,237 men and women, 25- to 70-years old, provided dietary and lifestyle information at study baseline (1992 to 2000). Over a median follow-up time of 12 years, 3,759 incident CRC cases were identified. The association between a HLI and CRC risk was evaluated using Cox proportional hazards regression models and population attributable risks (PARs) have been calculated. Results: After accounting for study centre, age, sex and education, compared with 0 or 1 healthy lifestyle factors, the hazard ratio (HR) for CRC was 0.87 (95% confidence interval (CI): 0.44 to 0.77) for two factors, 0.79 (95% CI: 0.70 to 0.89) for three factors, 0.66 (95% CI: 0.58 to 0.75) for four factors and 0.63 (95% CI: 0.54 to 0.74) for five factors; P-trend <0.0001. The associations were present for both colon and rectal cancers, HRs, 0.61 (95% CI: 0.50 to 0.74; P for trend <0.0001) for colon cancer and 0.68 (95% CI: 0.53 to 0.88; P-trend <0.0001) for rectal cancer, respectively (P-difference by cancer sub-site = 0.10). Overall, 16% of the new CRC cases (22% in men and 11% in women) were attributable to not adhering to a combination of all five healthy lifestyle behaviours included in the index. Conclusions: Combined lifestyle factors are associated with a lower incidence of CRC in European populations characterized by western lifestyles. Prevention strategies considering complex targeting of multiple lifestyle factors may provide practical means for improved CRC prevention.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gaia Data Release 1: the archive visualisation service

  • Moitinho, A.
  • Krone-Martins, A.
  • Savietto, H.
  • Barros, M.
  • Barata, C.
  • Falcão, A. J.
  • Fernandes, T.
  • Alves, J.
  • Gomes, M.
  • Bakker, J.
  • Brown, A. G. A.
  • González-Núñez, J.
  • Gràcia Abril, G.
  • Gutiérrez-Sánchez, R.
  • Hernández, J.
  • Jordan, S.
  • Luri Carrascoso, Xavier
  • Merin, B.
  • Mignard, F.
  • Mora, A.
  • Navarro, Vicente
  • O&apos;Mullane, William
  • Sagristà, T.
  • Salgado, J.
  • Segovia, J. C.
  • Utrilla, E.
  • Arenou, Frédéric
  • Bruijne, J. H. J. de
  • Jansen, F.
  • McCaughrean, M.
  • O&apos;Flaherty, K. S.
  • Prusti, Timo
  • Taylor, M. B.
  • Vallenari, A.
Context. The first Gaia data release (DR1) delivered a catalogue of astrometry and photometry for over a billion astronomical sources. Within the panoplyof methods used for data exploration, visualisation is often the starting point and even the guiding reference for scientific thought. However, this is a volume of data that cannot be efficiently explored using traditional tools, techniques, and habits. Aims. We aim to provide a global visual exploration service for the Gaia archive, something that is not possible out of the box for most people. The service has two main goals. The first is to provide a software platform for interactive visual exploration of the archive contents, using common personal computers and mobile devices available to most users. The second aim is to produce intelligible and appealing visual representations of the enormous information content of the archive. Methods. The interactive exploration service follows a client-server design. The server runs close to the data, at the archive, and is responsible for hiding as far as possible the complexity and volume of the Gaia data from the client. This is achieved by serving visual detail on demand. Levels of detail are pre-computed using data aggregation and subsampling techniques. For DR1, the client is a web application that provides an interactive multi-panel visualisation workspace as well as a graphical user interface. Results. The Gaia archive Visualisation Service offers a web-based multi-panel interactive visualisation desktop in a browser tab. It currently provides highly configurable 1D histograms and 2D scatter plots of Gaia DR1 and the Tycho-Gaia Astrometric Solution (TGAS) with linked views. An innovative feature is the creation of ADQL queries from visually defined regions in plots. These visual queries are ready for use in the Gaia Archive Search/data retrieval service. In addition, regions around user-selected objects can be further examined with automatically generated SIMBAD searches. Integration of the Aladin Lite and JS9 applications add support to the visualisation of HiPS and FITS maps. The production of the all-sky source density map that became the iconic image of Gaia DR1 is described in detail. Conclusions. On the day of DR1, over seven thousand users accessed the Gaia Archive visualisation portal. The system, running on a single machine, proved robust and did not fail while enabling thousands of users to visualise and explore the over one billion sources in DR1. There are still several limitations, most noticeably that users may only choose from a list of pre-computed visualisations. Thus, other visualisation applications that can complement the archive service are examined. Finally, development plans for Data Release 2 are presented.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  • Ward, Heather A.
  • Whitman, Julia
  • Muller, David C.
  • Johansson, Mattias
  • Jakszyn, Paula
  • Weiderpass, Elisabete
  • Palli, Domenico
  • Fanidi, Anouar
  • Vermeulen, Roel
  • Tjønneland, Anne
  • Hansen, Louise
  • Dahm, Christina C.
  • Overvad, Kim
  • Severi, Gianluca
  • Boutron-Ruault, Marie-Christine
  • Affret, Aurélie
  • Kaaks, Rudolf
  • Fortner, Renée T.
  • Boeing, Heiner
  • Trichopoulou, Antonia
  • Vecchia, Carlo La
  • Kotanidou, Anastasia
  • Berrino, Franco
  • Krogh, Vittorio
  • Tumino, Rosario
  • Ricceri, Fulvio
  • Panico, Salvatore
  • Bueno de Mesquita, H. Bas
  • Peeters, Petra H. M.
  • Nøst, Therese Haugdahl
  • Sandanger, Torkjel M.
  • Quirós, José Ramón
  • Agudo, Antonio
  • Rodríguez Barranco, Miguel
  • Larrañaga, Nerea
  • Huerta Castaño, José María
  • Ardanaz, Eva
  • Drake, Isabel
  • Brunnström, Hans
  • Johansson, Mikael
  • Grankvist, Kjell
  • Travis, Ruth C.
  • Freisling, Heinz
  • Stepien, Magdalena
  • Merritt, Melissa A.
  • Riboli, Elio
  • Cross, Amanda J.
Background: Epidemiological studies suggest that haem iron, which is found predominantly in red meat and increases endogenous formation of carcinogenic N-nitroso compounds, may be positively associated with lung cancer. The objective was to examine the relationship between haem iron intake and lung cancer risk using detailed smoking history data and serum cotinine to control for potential confounding. Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC), 416,746 individuals from 10 countries completed demographic and dietary questionnaires at recruitment. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident lung cancer (n = 3731) risk relative to haem iron, non-haem iron, and total dietary iron intake. A corresponding analysis was conducted among a nested subset of 800 lung cancer cases and 1489 matched controls for whom serum cotinine was available. Results: Haem iron was associated with lung cancer risk, including after adjustment for details of smoking history (time since quitting, number of cigarettes per day): as a continuous variable (HR per 0.3 mg/1000 kcal 1.03, 95% CI 1.00-1.07), and in the highest versus lowest quintile (HR 1.16, 95% CI 1.02-1.32; trend across quintiles: P = 0.035). In contrast, non-haem iron intake was related inversely with lung cancer risk; however, this association attenuated after adjustment for smoking history. Additional adjustment for serum cotinine did not considerably alter the associations detected in the nested case-control subset. Conclusions: Greater haem iron intake may be modestly associated with lung cancer risk.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  • Assi, Nada
  • Moskal, Aurelie
  • Slimani, Nadia
  • Viallon, Vivian
  • Chajès, Véronique
  • Freisling, Heinz
  • Monni, Stefano
  • Knüppel, Sven
  • Förster, Jana
  • Weiderpass, Elisabete
  • Luján Barroso, Leila
  • Amiano, Pilar
  • Ardanaz, Eva
  • Molina Montes, Esther
  • Salmerón, Diego
  • Quirós, José Ramón
  • Olsen, Anja
  • Tjønneland, Anne
  • Dahm, Christina C.
  • Overvad, Kim
  • Dossus, Laure
  • Fournier, Agnès
  • Baglietto, Laura
  • Fortner, Renée T.
  • Kaaks, Rudolf
  • Trichopoulou, Antonia
  • Bamia, Christina
  • Orfanos, Philippos
  • Santucci de Magistris, Maria
  • Masala, Giovanna
  • Agnoli, Claudia
  • Ricceri, Fulvio
  • Tumino, Rosario
  • Bueno de Mesquita, H. Bas
  • Bakker, Marije F.
  • Peeters, Petra H. M.
  • Skeie, Guri
  • Braaten, Tonje
  • Winkvist, Anna
  • Johansson, Ingegerd
Objective: Pattern analysis has emerged as a tool to depict the role of multiple nutrients/foods in relation to health outcomes. The present study aimed at extracting nutrient patterns with respect to breast cancer (BC) aetiology. Design: Nutrient patterns were derived with treelet transform (TT) and related to BC risk. TT was applied to twenty-three log-transformed nutrient densities from dietary questionnaires. Hazard ratios (HR) and 95 % confidence intervals computed using Cox proportional hazards models quantified the association between quintiles of nutrient pattern scores and risk of overall BC, and by hormonal receptor and menopausal status. Principal component analysis was applied for comparison. Setting: The European Prospective Investigation into Cancer and Nutrition (EPIC). Subjects: Women (n 334 850) from the EPIC study. Results: The first TT component (TC1) highlighted a pattern rich in nutrients found in animal foods loading on cholesterol, protein, retinol, vitamins B12 and D, while the second TT component (TC2) reflected a diet rich in β-carotene, riboflavin, thiamin, vitamins C and B6, fibre, Fe, Ca, K, Mg, P and folate. While TC1 was not associated with BC risk, TC2 was inversely associated with BC risk overall (HRQ5 v. Q1=0·89, 95 % CI 0·83, 0·95, Ptrend<0·01) and showed a significantly lower risk in oestrogen receptor-positive (HRQ5 v. Q1=0·89, 95 % CI 0·81, 0·98, Ptrend=0·02) and progesterone receptor-positive tumours (HRQ5 v. Q1=0·87, 95 % CI 0·77, 0·98, Ptrend<0·01). Conclusions: TT produces readily interpretable sparse components explaining similar amounts of variation as principal component analysis. Our results suggest that participants with a nutrient pattern high in micronutrients found in vegetables, fruits and cereals had a lower risk of BC.